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ABSTRACT
Acute respiratory viral infection (ARVI) represents one of the most prevalent infectious diseases
affecting mankind. With the threat of COVID-19 still looming over us, we have witnessed the
substantial threat ARVI poses to world health and economy, extinguishing millions of lives and
costing trillions of dollars. This sets the context for the research of this thesis: using digital
biomarkers to distinguish between individuals who are susceptible to becoming severely infected
and/or infectious before an infection is clinically detectable. The development of such biomarkers
can have both clinical and epidemiological impact in terms of identifying individuals who are either
vulnerable to severe infection or those who may become highly infectious. The digital biomarkers
and associated analysis methods are developed and validated on longitudinal data collected by our
clinical collaborators from two different ARVI challenge studies. The first study provides data on
healthy human volunteers who were inoculated with the common cold and the second study provides
data on volunteers inoculated with the flu. Digital biomarkers include molecular, physiological
and cognitive data continuously collected from blood, wearable devices and cognitive testing of
the study participants. The findings of our research on digitally measurable susceptibility factors
are wide-ranging. We find that circadian rhythm at the molecular scale (biochronicity) plays an
important role in mediating both the susceptibility and the response to severe infection, revealing
groups of gene expression markers that differentiate the responses of low infected and high infected
individuals. Using a high dimensional representation of physiological signals from a wearable
device, we find that an infection response and its onset time can be reliably predicted at least 24
hours before peak infection time. We find that a certain measure of variability in pre-exposure




1.1 Motivation and Research Background
First we provide motivation for the work described in this thesis. We then provide some
background on the mechanisms of infection and susceptibility, digital biomarkers, circadian rhythm.
We conclude the introduction with an outline of the contributions of the thesis.
1.1.1 Motivation
Acute respiratory infections have similar clinical symptoms including fever, runny nose, cough-
ing, stuffed nose, sore throat, malaise etc. Colds, influenza, pneumonia, and COVID-19 are all
examples of acute respiratory infections. Although numerous pathogens cause respiratory illness,
over 80% cases are viral [MPR+98]. The high diversity and fast mutation rates of viruses makes
it difficult to develop effective detection, prevention and treatment strategies for acute respiratory
viral infection.
Acute respiratory viral infection (ARVI) is a serious health and economic concern worldwide.
While a mild common cold is often self-limited and can be resolved without treatment in 1-2 weeks
for healthy individuals, other forms of ARVI can be much more dangerous. Acute respiratory
viral infection is a leading cause of morbidity, hospitalization, and mortality with a global illness
burden of millions of deaths [ML97]. COVID-19 alone has infected approximately 200 million
individuals and claimed the lives of 4 million within less than 2 years [JHU]. ARVI treatment
and control, including but not limited to quarantine, screening, medical treatment and vaccine,
have global costs in the billions or trillions of dollars [JWL+21]. A tantalizing hypothesis is that
susceptibility to severe ARVI can be predicted using digital biomarkers before a person becomes
symptomatically ill. If this were possible on a large scale, then one could forecast symptom severity
and degree of infectiousness (viral shedding) of individuals in a population. This would clearly
have profound implications on prospective disease prevention and treatment, and on our ability to
manage pandemics by identifying and protecting vulnerable individuals. This thesis makes a step in
this direction by investigating the value of digital biomarkers that are collected over time before
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exposure and during infection. Using multi-modal digital biomarker data collected from challenge
studies designed and executed by our clinical collaborators, we develop methods of analysis and
make findings that may one day help early detection of susceptibility to ARVI.
1.1.2 Background: Human Viral Challenge (HVC) studies
Human Viral Challenge (HVC) studies have long been conducted to understand various aspects
during infection by deliberately infecting volunteers with a pathogen of interest[LWNM+18].
They can be traced back to the famous smallpox challenge of James Phipps by Edward Jenner in
1796[DCM03]. HVC studies can provide valuable information on susceptibility factors, disease
pathogenesis, diagnostic biomarkers and / or vaccine efficacy, depending on the design and purpose
of the experiment [BHPB17].
An illustration of the experimental process and the data processing pipeline for the execution
of a Human Viral Challenge (HVC) experiment and the analysis of its data is shown in Fig. 1.1.
After a group of volunteers has been selected and pre-screened, they are monitored before and after
being exposed to a viral pathogen. Associated molecular, physiological, and cognitive samples
are gathered from each individual throughout time. Data extracted from these samples are called
digital biomarkers. For molecular data these biomarkers are derived from gene sequencing data or
metabolomic, proteomic assays. For physiological data, these biomarkers are derived from signals
extracted from wearable devices, signals such as electrodermic activity (EDA), skin temperature,
heart rate (HR), or acceleromenter (ACC) measuring physical movement. After inoculation some
study participants may become symptomatically ill with viral shedding, some participants may
have few or no symptoms but have viral shedding, others may have symptoms but no shedding,
while others may have neither symptom nor shedding. The symptoms and shedding levels are also
measured during the study, becoming part of the digital biomarker databases.
To build a predictive analysis framework for analyzing these digital biomarkers the data must first
be pre-processed, often involving various forms of data cleaning, formatting and outlier detection.
Then feature extraction is performed, often involving a combination of mathematical procedures,
e.g., PCA or sparse logistic regression, and biological domain knowledge. Methods of statistical
learning are increasingly employed to develop robust and generalizable predictors based on a
minimum of domain knowledge.
Data from two HVC studies are used in this dissertation. The first study performed in 2015
at the University of Virginia, called the Biochronicity study, recruited 24 volunteers and their
molecular, physiological, hormonal and cognitive samples were collected both before and after
the inoculation of Human Rhinovirus (HRV). This experiment was designed to explore the role
of biochronicity in infection susceptibility and infection response. The results of Chapter 2 and
Chapter 4 are based on analysis of data from this experiment. The other study, called Prometheus,
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challenged 39 individuals with influenza virus. The Prometheus challenge study was performed at
University College London in 2017. The experiment was designed to establish the feasibility of
predicting infectiousness, measured by amount of shedding, of infected participants before peak
symptom occurs. The wearable data from this experiment was used in Chapter 3. Detailed protocol
and information of these experiments will be described in details in corresponding chapters.
1.1.3 Background: Mechanisms of infection and susceptibility
Systemic acute respiratory viral infection occurs when a viral pathogen enters the body of the
host, often through the naso-pharyngal mucosa, and replicate sufficiently that it is able to travel
and invade multiple cells throughout the respiratory tract. The success of the virus in infecting
the host is determined by many factors, the major factor being the effectivenss of host immune
response. Molecular mechanism of host immune response has been investigated both in vitro and
in vivo. Viruses are detected by pattern recognition receptors (PRRs) which recognize pathogen-
associated molecular patterns (PAMPs). Important PRRs include NOD-like receptors (NLRs),
Toll-like receptors (TLRs), retinoic acid-inducible gene I (RIG-I), and other cytosolic virus sensors.
Interferons (IFNs) and other proinflammatory mediators (e.g. cytokines, chemokines) are released
when these PRRs are activated, triggering the host’s innate and adaptive immune responses[NCB16].
A set of peripheral blood gene expression signatures containing different PPRs has been identified
to precisely distinguish individuals with symptomatic ARVIs from resistant individuals [ZCV+09b].
Different temporal host molecular responses were examined in symptomatic hosts and asymptomatic
subjects. Multiple PRRs-mediated antiviral and inflammatory responses were invoked in the former
while the latter has increased expression of genes with annotations related to antioxidant responses
and cell-mediated responses [HZR+11]
There are many factors that influence population vulnerability. Sometimes genotype is one
reason why some people are more vulnerable than others. For example, ACE2 gene is known
to encode the entry receptor for SARS-CoV-2, whose genetic polymorphisms may influence the
binding affinity and the subsequent cell invasion efficiency [GPPK+20]. Aside from genotype,
infection susceptibility is influenced by lifestyle. Sleep deprivation has been shown in studies to
have a negative impact on immune system components that are important for host resistance to
infectious disease [PL16]. Specifically, short sleep duration and sleep disruptions indicate greater
susceptibility to upper respiratory infection [PJDHC15, CDA+09]. In addition, longer duty hours,
stress, shift work and poor sleep quality appeared to be a risk factor to infectious diseases such as
COVID-19 [RCW+20].
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1.1.4 Background: Digital Health
Wearable digital devices, databases, and technologies have fundamentally changed healthcare
and disease prevention [MDB+17] Device technologies are now commonly utilized in a variety of
medical and healthcare settings. For example, cardiac pacemakers help arrhythmia patients and
digital hearing aids provide relief to the hearing impaired. Sequencing technologies are used to
perform genotyping and screen for genetic predisposition to certain diseases. Database technologies
such as digitalized health information systems facilitate health care workers to better serve patients
and health care researchers to make important scientific discoveries.
Among wearable digital devices, the most relevant to this dissertation are wearable biosen-
sors and online mental assessment tools, which collect data directly from patient interaction with
tablets or smart phones. These devices can monitor physiological health and psychological health,
respectively [Lup13, BSB19]. Wearable physiological biosensors can capture a wide range of
physiological data, including activities (measured with accelerometer), body temperature, blood
pressure, blood volume pulse, electrocardiogram(ECG), electrodermal activity, etc. Likewise, men-
tal states like stress, and cognitive functions, like response time, can be regularly and conveniently
sensed by user-engagement with applications on portable devices. Mental and cognitive states
have been found to be associates with physical health and vice-versa [Gaz00, CWH+05, VLM+11].
Thus a combination of wearable physiological biosensors and portable mental and cognitive state
sensors allow for real-time monitoring of health conditions without the need for intrusive methods or
hospitalization. This could lead to better patient compliance with treatments or prevention protocols.
As previously indicated, poor lifestyle choices have long been recognized as risk factors for ARVI.
It is a theoretically plausible conjecture that if we pick the right combinations of sensors with
appropriate feature extraction, we may infer knowledge on lifestyle. This might permit us to go one
step further to forecast disease vulnerability on an individual level.
1.1.5 Background: Circadian rhythm
Periodic phenomenon are observed to be ubiquitous at many different levels and scales of
biological activity. A prominent example is the set of cyclic variations in animal and human
behaviors, including sleep–wake cycles and feeding. Physiology parameters like body temperature
blood pressure also fluctuate with a period of around 24 hours. With the advancement of molecular
biology, concentrations of some molecules were also found to be cyclic, including hormone secretion
and genes expression [SLL+02, ZLB+14]. A phenomenon that exhibits periodicity with period
∼24h is siad to have circadian rhythm (stemming from Latin circa diem, about a day). Circadian
rhythms manifests across behavior, physiology, metabolism, and gene expression. However, the
circadian cycling phases may be different depending on lifestyle, sleep habits, and body tissue type
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that is assayed.
How is circadian rhythm organized in so many different aspects and tissues? The physiological
structural basis is a hierarchical network of central and peripheral oscillators. The master pacemaker
locates at ∼15,000-cell suprachiasmatic nucleus (SCN) [GR10, EMSC09], a region of the brain
in the hypothalamus. Circadian rhythm in peripheral tissues is subject to orchestration by the
central clock through endocrine and neural output [AS05, SGS+15]. It is worth mentioning that
a central pacemaker of SCN is not necessary for peripheral tissues to maintain circadian rhythm.
Many cultured in vitro peripheral tissue experiments have exhibited comparable self-sustained
circadian oscillations in the absence of the central pacemaker SCN [YYL+04]. The relationship
between central pacemaker and peripheral clock represents two characteristics of circadian rhythm:
self-sustained and entrainable. The peripheral clock is self-sustained while it is under orchestration
of the central pacemaker SCN. With entrainment, circadian clock is able to adjust phases to adapt to
external environmental cues, including light/dark cycles, food intake, stress, and exercise.
The underlying molecular mechanism of the self-sustained circadian clock is based on a compli-
cated network of interlocked transcriptional-translational feedback loops (TTFLs) [THKM08]. The
core components of mammalian circadian clock machinery are the clock proteins. An illustraction
of TTFLs is shown in Fig. 1.2. This figure was published in [THKM08]. Besides TTFL, other
mechanisms, like redox states and post-translation modification of proteins, regulate circadian
rhythm as well [EGZ+12, GV07].
Interrupted circadian rhythm has been proven to increase risk for many diseases. Disrupted
rhythm can also lead to health hazards, as illustrated by the fact that shift workers are more
vulnerable for diseases including cardiovascular disease, stroke, type 2 diabetes, and cancer
[SLS+01, SHMS09, SBG+07, PSSH11, BFS+09] .
On the other hand, some diseases also affect the circadian clock. It is known that Alzheimer’s dis-
ease, cancer, and severe sepsis cause abnormal circadian rhythm in mammals [AOCC15, MBCG05,
CC08, SCVO13, MVDC+10, MDKK+02, PB08, TYH+01, OYD+08]. Traditionally circadian
rhythm was expected to be totally lost during severe acute infection. Recently a study challenged
the traditional idea with LPS-induce endotoxemic mice [HCS+14]. They found that despite most of
baseline cyclers ceased to be periodic after infection, more genes astonishingly gained periodicity
during endotoxemia. Functional annotation analysis was performed to discover the enrichment
of immune-related processes in the novel cyclers in endotoxemia. A follow on in vitro research
experiment provided additional supporting that a unique set of novel cyclers were gained in mice
with tissue-specific disruption of BMAL1 [ZHW+19], a clock gene. This set has almost the same
size compared to the number of cyclers only found in BMAL1flox/flox mice.
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1.2 Thesis Outline and Contributions
In Chapter 2, a bio-longitudinal viral challenge study was performed on a human cohort during
which different types of biomarkers were collected for analysis. We investigated the temporal
evolution of these biomarkers and evaluated their periodicity in basal state and after inoculation.
This is the first systematic study on the interplay between circadian rhythm and immune response in
a human in vivo experiment. While a large number of novel cyclers were identified after inoculation,
this observation, together with two earlier studies [HCS+14, ZHW+19], suggests that circadian
components could have quite different composition when the host is perturbed from a normal
condition, e.g., by introduction of a viral pathogen. We make several striking discoveries in the
context of our analysis of the Biochronicity human viral challenge study. First, baseline cycling
genes selectively undergo cycle extinguishment depending on their phase angles; those that attain
minimum cycle amplitude nearer the time of inoculation are more likely to lose periodicity. Second,
baseline cyclers are much stronger in low shedders than in high shedders, which suggests that
chronotype strength could potentially be used as a predictor of susceptibility. A transcription
regulation database was incorporated to map the genes involved in immune response and circadian
rhythm with their upstream transcription factors. Key parts of JAK-STAT pathway and NF-κB
and its subunit RELA are at the center of the immune response module and the circadian module,
respectively. We also find that these two sets of master regulators are buffered by other genes
discovered in our analysis. These buffering genes might explain the resilience of the clock to
immune response and the emergence of circadian rhythm in certain genes after inoculation.
In Chapter 3, an adaptive transfer learning algorithm was introduced to address the data covariate
shift problem in wearable data. Using a multivariate hidden Markov model (HMM) and Fisher’s
linear discriminant analysis (FLDA) the algorithm adaptively adjusts to shifts in distribution over
time. The proposed algorithm is unsupervised and learns to label events without requiring a priori
information about true event states. Simulations validate the effectiveness of the proposed adaptive
algorithm, which significantly outperforms other event classification methods. When applied to
early time points in the HVC data, the algorithm extracts sleep/wake features that are predictive of
both infection and infection onset time.
In Chapter 4, a score, named cognitive performance variability (CPV), is developed to represent
the variability of an individual’s performance on a repeated sequence of cognitive tests during
pre-exposure baseline, which is found to be highly associated with future viral shedding. CPV is
robust to sampling and sessions. Our results suggest that pre-exposure cognitive function variability
is closely related to viral shedding, opening the intriguing possibility that periodic cognitive testing
could be useful in predicting susceptibility to infection.
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(a) Illustration of the experimental process of Human Viral Challenge (HVC)
experiment. After a group of volunteers has been selected and pre-screened, they
are monitored before and after being exposed to the virus. Related biological
samples or other signal, information responses will be gathered throughout time.
Participants will have various levels of symptoms after being inoculated, and they
will eventually recover.
(b) Illustration of data processing of Human Viral Challenge (HVC) experiment.
Pre-processing of diverse forms of data acquired in the experiment with various
origins will be done first, and then features will be extracted, usually using domain
expertise. Statistical learning approaches would be employed to answer the issue
that the HVC research is meant to address.
Figure 1.1: Illustration of experimental process and data processing of Human Viral Challenge
(HVC) experiment.
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Figure 1.2: Illustration of transcriptional-translational feedback loops (TTFL) as the mammalian
circadian clock machinery. This figure is cited from [THKM08].
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CHAPTER 2
Rhinovirus Infection and the Rhythms of Health: A Multispectral Challenge
Study in a Human Cohort
2.1 Introduction
The rhythms of health are manifested across behavioral, physiological, metabolic, and genomic
domains of the human condition. For a healthy individual, sleep, mental state, blood pressure, heart
rate, and molecular (gene, protein, metabolite) expression express in a steady (circadian) pattern
within a 24 hour cycle and from day to day, but are subject to modulation by external environmental
stimuli. Mechanisms underlying circadian rhythms and their contribution to the health of individuals
have been elucidated in [THKM08]. Ways that these rhythms become perturbed due to exposure to
stressors in the environment have been studied in [ALML+14]. Links between circadian rhythms
and optimal timing of drug treatments to achieve maximal effectiveness, i.e., circadian chemotherapy
and other chronotherapies have also been of interest [Hru85].
This chapter studies the sensitivity of circadian rhythms to an acute health perturbation: a
one-time exposure to an infection-causing pathogen. Specifically, a challenge study was designed
and a cohort of human volunteers was recruited to participate in an ambitious longitudinal study
involving monitoring over 19,000 biomarkers from 5 different biomarker types, including clinical,
cognitive, physiological, metabolic, and genomic modalities measured in blood, nasal fluids, human-
machine-interactions, and activity logged by wearable devices. Importantly, this challenge study was
bio-longitudinal – multiday time samples of biomarkers were collected both and after inoculation.
These samples were collected from the cohort over an 8 day period, collected at least 3 times per
day, and an inoculation by live virus (human rhinovirus, HRV) was administered on the fourth day,
perturbing the healthy baseline of each subject in the study. This challenge study offers a unique
glimpse into the exposome over time with a rich multimodality view across multiple scales. This is
the first systematic study on the interplay between circadian rhythm and immune response in an in
vivo human experiment.
Our analysis reveals novel exposome chronotypes associated with the effect of the viral inoc-
ulation, manifested across all biomarker types collected in the challenge study. Many circadian
10
biomarkers largely remain resilient to the viral insult. Biomarkers that are strongly circadian
throughout the baseline and post-inoculation time periods include: cortisol (a steroid associated
with stress [HWK09]), DDIT4 (a gene identified as a monitor for human circadian rhythm in blood
transcriptome [LMLP+17, Hug17, LCJ+21] ), and heart rate (modulated by the wake/sleep cycle).
We find that among all cycling biomarkers, it is the circadian rhythm of gene expression that is
by far the most perturbed by exposure. We observe that the perturbation by inoculation results
in quenching (extinguishment) of the circadian cycling of certain baseline cycling genes while it
results in recruitment circadian cycling of some baseline non-cycling genes. Among biomarkers
that are recruited is the poly(A) RNA polymerase D7 (PAPD7), a gene that adds poly(A) to various
classes of nuclear RNAs and has been found to be essential to Hepatitis B Virus RNA stabilization
[OCH13, ZYL+19]. As a large number of novel cyclers were identified after inoculation, this obser-
vation, together with two earlier studies [HCS+14, ZHW+19], suggests that circadian components
could have quite different compositions when the host is perturbed from a normal condition, e.g.,
by introduction of a viral pathogen.
Our analysis also reveals that the quenching of gene cycling is phase-selective. Specifically,
among genes of all cycling phases, cycling genes with phase minima around inoculation time (8am)
are the most likely to lose their periodicity after inoculation. Conversely, cycling genes that have
phases achieving their maximum expression level at inoculation time, are most likely to retain their
periodicity. Circadian cycling of metabolites is also most resilient at inoculation time where the
metabolites are at their maximum concentration, but the phase-selective quenching effect is not
as strong. Such phase-selective disruption of circadian cycling may have significant preventative
health implications.
Last but not least, our analysis reveals that those individuals who are not severely infected, as
measured by viral shedding and symptom, exhibit considerably stronger circadian cyclers both in
the basal condition and after inoculation then the rest of the cohort. This suggests that a lack of
strong biochronicity might be a predictor of susceptibility. In particular, if these findings hold up
in broader cohorts, the strength of a certain circadian cycling genes could be a possible predictor
of infectiousness, safeguarding susceptible people and aiding in infectious disease prevention and
treatment.
2.2 Results
2.2.1 Human viral challenge study
A longitudinal human rhinovirus (HRV) challenge study was designed at Duke University and
the University of Virginia and took place in 2015 over a nine day period. A total of 24 volunteers
were recruited into the study and 19 participants completed the study. One of these participants had a
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failed inoculation and was omitted from our analysis. The age range of the remaining 18 participants
was between 18 and 23, two thirds of these participants were male, and 4 were non-caucasian. For
a more detailed demographic summary see participant demographics are shown in Fig. 2.7 in the
Supplementary Materials. The study was reviewed and approved by the Institutional Review Boards
at Duke University and at University of Virginia. Written informed consent was obtained from all
participants. Exclusion criteria included pregnancy, chronic respiratory illness, high blood pressure,
tobacco/drug/alcohol history, and serum antibody levels above 1:4 titers. The participants were not
isolated during the study.
Fig. 2.1A summarizes the data collection protocol. On day four at 8am (denoted as time 0
on Fig. 2.1A) each participant was inoculated via intranasal drops of diluted Human Rhinovirus
strain type 16 with a dose of 100TCID50 in 1mL Lactated Ringer’s Solution. Between 7am and
9am on the morning of the fourth day of the study participants were inoculated with live HRV
virus. A histogram of the inoculation times is shown in Figure 2.8 in the Supplementary Materials.
Molecular, physiological, cognitive, clinical, and shedding data were collected at multiple time
points, annotated in time units (hours) on Fig. 2.1A.
The biomarker type, subtype and sampling rates of the data collection are indicated in Fig.
2.1B. Blood samples were collected three times per day from which molecular data was extracted
using RNAseq (genes), p180 (metabolites), and steroid assay (hormones). Physiological signals,
including physical activity (ACC), blood volume pulse (BVP), electrodermal activity (EDA) and skin
temperature (TEMP), were recorded continuously over time from wearable wristbands (Empatica
E4 devices). Cognitive ability, measured by 18 Lumos scores, and 8 self-reported symptom subtypes
were measured three times daily based on subject inputs to a tablet device. Finally viral shedding,
quantified by PCR viral titrations, was collected once per day from nasal washes.
Study participants reacted differently to the viral inoculation, with some becoming severely
symptomatically ill while others remaining largely symptom free. All participants had some level
of viral shedding; the total accumulated shedding over the post-inoculation periods is shown in
Fig. 2.1C. The entire population was divided into two sub-groups (low shedders and high shedders)
depending on whether their shedding failed to reach or exceeded the population median of 5.7
titers (vertical red line in the figure). In the sequel we will show that these two sub-groups have
distinct chronotypes in terms of their circadian cycling and non-cycling during baseline and post-
inoculation (Fig. 2.5). Shedding and symptom evolution over time for each subject is included in
the Supplementary Material (Fig. 2.9). There is a good linear correlation between total shedding
and total symptom (Fig. 2.10). Accumulated symptoms scores of all participants are shown in Fig.
2.11. The population are ordered by increasing total shedding levels from left to right. All high
shedders have more severe symptom than low shedders except for participant 19, indicating the
good coherence between shedding and symptom. We use total shedding in the following analysis to
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represent infectiousness for it is more objective compared to self-reported symptom score.
Figure 2.1: Challenge study protocol, data collection and clinical phenotype. A. Timeline of study
indicating the 3-day pre-inoculation period and the 5-day post-inoculation period along with times
of blood samples shown as bullets on timeline. HRV viral inoculation was administered on day 4 at
8AM (0 hours on timeline) immediately after sample collection. B. 5 diverse biomarker types were
collected over the course of 8-day study from 18 human volunteers. C. By computing the median
accumulated shedding level (indicated by the red vertical line), the entire population can be divided
into two sub-groups (low shedders and high shedders) based on their accumulated shedding levels
in response to the viral challenge. These two sub-groups were found to have very distinct types of
circadian patterns in both baseline and post-inoculation (see Fig. 2.5).
2.2.2 Distinct biomarker chronotypes over baseline and after viral exposure
We evaluated the circadian cycling of each biomarker by applying a statistical periodicity test
(JTK_CYCLE [HHK10]) at various levels of significance for the basal state (-72 to 0 hours) and
after viral exposure (0 to 104 hours), respectively. Consistent with previous studies [LMLP+17], we
found that many protein coding genes, metabolomic molecules, and physiological signals display
strong circadian behaviors in baseline. The chronotypes of some baseline cycling biomarkers are
resilient to the perturbation caused by pathogen exposure while others have disrupted chronotypes
as evidenced by cycling phase shift, cycling attenuation, or cycling extinguishment. Interestingly,
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some additional biomarkers were found whose circadian cycling appears to be recruited only after
inoculation.
2.2.2.1 The circadian landscape of different biomarkers in baseline and after exposure
The cycling of biomarkers was distinguished on the basis of four different strength levels (Strong,
Medium, Weak and Non-cycling), determined by the level of significance of the JTK_CYCLE
cycling test (see Supplementary Material 2.6 for a precise definition and illustrations, e.g. Fig.
2.12). A biomarker is cycling if it is a strong, medium or weak cycler and otherwise it is said to be
non-cycling.
Figures 2.2A & 2.2B show the proportion and number of circadian cycling biomarkers at dif-
ferent cycling strength levels in baseline (BL) and post-inoculation (PI), respectively. Among all
biomarker types, Lumos cognitive biomarkers had the least amount of circadian cycling, exhibiting
no cycling in either BL or PI according to the JTK_CYCLE significance test at level 0.05. Partici-
pants’ cognitive performance improved over time as they became more familiar with the games.
That is the reason why Lumos variables has no cycling property. The cognitive biomarkers will not
be discussed further.
Among the other biomarker types, gene expression (RNAseq) had the most cyclers at all cycling
strength levels (Top panel of Fig. 2.2A) in both baseline and post-inoculation time intervals, but
it had the lowest proportion of cyclers relative to the total number of RNAseq biomarkers (Top
of Fig. 2.2B). 45 (0.23%) genes are strongly periodic in baseline, while 364 (1.86%) genes have
medium periodicity strength and another 1,475 (7.55%) genes are weakly periodic in baseline. In
post-inoculation, there are only 11 (0.06%) strong gene cyclers, 109 (0.56%) medium gene cyclers
but 2,374 (12.14%) weak gene cyclers. The most enriched KEGG pathway of significant baseline
cycles with any strength is Chemokine signaling pathway, while the post-inoculation novel cyclers
has enrichment in Protein processing in endoplasmic reticulum. Metabolites measured by p180
assay (Second from top panel of Figs. 2.2A and 2.2B) have 7 (3.85%) strong cyclers, 24 (13.19%)
medium cyclers and 64 (35.16%) weak cyclers in baseline, and the numbers go down to 2 (1.1%)
strong cyclers, 20 (10.99%) medium cyclers and 62 (34.07%) weak cyclers after viral exposure.
Metabolites including mino acid, urea and different kinds of lipids were found to be rhythmic in a
previous research. [EMSC13].
Physiological features (second from bottom panel of Figs. 2.2A and 2.2B) were extracted from
E4 wristband measurements using the methods described in [SZH+20] (Supplementary Materials).
These physiological biomarkers exhibit the highest proportion of strong cyclers as compared to
genes and metabolites. In baseline, all features related to heart rate (HR), activity (ACC) and body
temperature (TEMP) are strongly cycling while in EDA, there are no strong cyclers (EDA_sd is
medium cycling). It is not surprising that heart rate and body temperature fluctuate around a 24-hour
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period in tandem with the sleep-wake cycle [MMW+00, BWV+01]. However, the rhythmicity
of ACC_median degrades from strong to medium cycling and TEMP_median and TEMP_mean
are transformed to weak cyclers after viral exposure. Interestingly, while non-cyling in BL, in
post-inoculation EDA_median and EDA_mean emerge as medium strength cyclers in PI. Despite
circadian variations are not neglectable [KKB+18], electrodermal activity (EDA) is more regulated
by the activation of the autonomic nervous system, when sweat gland stimulation increases the
electrical conductivity of the skin[ZFS91]. It is also related with stressful events [SAS+09].
Among all biomarkers, the cycling behavior of hormones (bottom panel of Figs. 2.2A and
2.2B) is most resilient to the viral perturbation; there is no change in their cycling strength after
viral exposure. Two out of the three hormones measured in this study, melatonin and cortisol, have
previously been reported as markers of circadian rhythm [JCB07]. These hormones retain their
strong periodicity from BL to PI. Another hormone, dehydroepiandrosterone (DHEAS), is weak
cycling both in basal state and after exposure. (See Supplementary Material Fig. 2.18, Fig. 2.19
and Fig. 2.20 for their concentration over time.)
2.2.2.2 Impact of perturbation on circadian cycling
In addition to the general circadian landscape of the sets of biomarkers that cycle in baseline and
post-inoculation, shown in Figs. 2.2A and 2.2B, the fate of individual BL cyclers is also of interest.
Figures 2.2C and 2.2D show that a cycler’s ability to maintain its cycling after inoculation depends
on its strength of cycling at baseline. If a baseline cycler become non-cycling after inoculation, it is
called a BL-only chronotype. Conversely, a biomarker is a PI-only chronotype if it is non-cycling in
baseline and acquires significant periodicity after exposure. Another type of cycler are the resilient
chronotype who maintain their rhythm in both BL and PI. The number of these three chronotypes
are shown in Fig. 2.2C for different cycling strength levels (JTK_CYCLE false discovery rate,
FDR). Proportionately to all baseline cyclers (including both the BL-only and resilient chronotypes)
we show the percent of each chronotype in Fig. 2.2D. The rightmost bar in Figs. 2.2C and 2.2D
indicates cyclers at any strength level (FDR < 0.05) and demonstrates that approximately 30% (611
of the 1,992) baseline-cycling biomarkers are resilient chronotypes, i.e., they continue cycling after
inoculation. Furthermore, there are more biomarkers that only cycle in post-inoculation (1,982,
99.5%) than those that only cycle in baseline (1,381, 69.3%). However, in both cases most of
post-inoculation chronotypes are weak cyclers, i.e., they have JTK_Cycle FDR between 0.001 and
0.05.
The leftmost bar of the barplot in Figs. 2.2C and 2.2D shows only the strongest cyclers
(JTK_Cycle FDR < 0.000001), which only includes just 67 biomarkers. These strong baseline
and post-inoculation cycling biomarkers are listed along with their FDR and cycling phases in the
Supplementary materials and include biomarkers of every type except for Lumos, which, as pointed
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out above, does not exhibit cycling at any strength level (JTK_CYCLE FDR< 0.05). Approximately
27% (17) of the 63 strong BL-cycling biomarkers continue to cycle after inoculation. Remarkably,
there are many more genes with the BL-only chronotype than with the PI-only chronotype.
From weaker to stronger cyclers (left to right of Figs. 2.2C and 2.2D) we observe that the
proportion of genes with resilient chronotype, starts to decrease from 27% to ∼10% as the FDR
cutoff loosens from 0.000001 to 0.001, then increases to ∼30% as the FDR cutoff increases to 0.05.
The proportion of genes with PI-only chronotype has a nearly monotonic increasing trend as the
FDR cutoff increases, and as the number of all baseline cyclers also increases. The perturbations of
cycling strength due to inoculation will be further discussed in Sec. 2.2.5.1.
2.2.2.3 Impact of perturbation on biomarker expression levels.
In addition to having an effect on circadian cycling, the viral inoculation has an effect on the
average measured levels of the biomarkers. For the RNAseq, 467 (2.4%) genes were up-regulated
and 2,106 (10.8%) genes were down-regulated after inoculation when compared to baseline. A
pathway enrichment analysis (See 2.4 in Methods for details) shows that the most enriched pathways
for the up-regulated genes are NOD-like receptor signaling (FDR 7.86e-12) and Influenza A (FDR
7.86e-12), while the most enriched pathways for the down-regulated genes are Spliceosome (FDR
5.68e-23), Ribosome(FDR 2.70e-13), RNA transport (FDR 2.70e-13) and protein processing in
endoplasmic reticulum (FDR 4.11e-11).
As contrasted to the genes, none of the metabolites’ concentrations rose significantly after
inoculation. However, 15 (8.2%) metabolite concentrations dropped in value with FDR < 0.05. The
mean levels of hormones and physiological features do not vary significantly between baseline and
post-exposure.
In summary, we found that genes have the largest number of cyclers and their rhythmicity is the
most sensitive to circadian disruption by viral exposure compared to other biomarker types. Thus
in the following subsections (Secs. 2.2.3-2.2.4) we focus on highlighting the cycling behaviors of
genes in baseline and how they change after inoculation. Similar analysis on other biomarker types
are included in the Supplementary Material.
2.2.3 Circadian genes in basal state
As described in 2.2.2.1, there are 45 STRONG cyclers, 364 MEDIUM cyclers and 1,475
WEAK cyclers in baseline (basal state) before perturbation. These sum up to a total of 9.6% of
the entire transcriptome. A KEGG pathway enrichment analysis (See 2.4 in Methods for details)
was performed and 108 out of 329 pathways tested are significantly enriched in the set of baseline
cycling genes, among which the top ranking pathways are Chemokine signaling pathway(FDR
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Figure 2.2: Cycling profiles of various biomarkers in baseline and post-inoculation. Panels A&B:
Count and proportion of cycling biomarkers with different strength in baseline (BL) and post-
inoculation (PI). (Strong cycler: FDR < 1e-6; Medium cycler: 1e-6 < FDR < 1e-3; Weak cycler:
1e-3 < FDR < 0.05). The genes have the lowest proportion but the largest number of cyclers,
and they are most susceptible to circadian disturbance due to viral exposure. Most physiological
features by E4 are strongly periodic. Hormones (Cortisol, Melatonin, DHEAS) are the most resilient
to the perturbation. Panel C: Total number of cycling biomarkers at different strengths having
unique cycling features (only cycling in baseline; cycling in both baseline and post-inoculation;
only cycling in post-inoculation). Panel D: Proportional biomarker cycling corresponding to Panel
C. Two types of BL cyclers add up to 100%. As the cycling strength threshold weakens from left to
right, the proportion of BL cyclers that maintain their periodicity (green bar segment) first starts
decreasing from FDR 0.000001 to 0.001, then increases as FDR cutoff goes to 0.05. The PI-only
cyclers (blue bar segment) increases both in number and in proportion as FDR cycling threshold is
loosened from strong to weak.
7.30E-13), Pathways in cancer(FDR 1.64E-12), Cytokine-cytokine receptor interaction (FDR 1.18E-
08), Natural killer cell mediated cytotoxicity (FDR 7.60E-08). The functions and pathways enriched
by baseline cyclers with different phases are depicted in 2.3A.
The phase and strength distribution of cyclers in the basal state is shown in 2.3B. Phase 20h
corresponds more than half (51%) of all baseline cyclers, and this phase accounts for even higher
composition in STRONG and MEDIUM cyclers (69% and 67%, respectively), compared to WEAK
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cyclers (46%). Other than Phase 20, Phase 12h has more strong cyclers than the rest, including
DDIT4, the gene with most significant periodicity in both baseline and post-inoculation. (See
Supplementary Material 2.15 for a plot of DDIT4 over time.)
Figure 2.3: Phase and strength distribution of baseline (BL) and post-inoculation (PI) cyclers, and
corresponding biological function annotations. Panel A: the phase distribution of baseline cyclers
and correspondingly enriched KEGG pathways of baseline cyclers. Panel B: the co-distribution of
phase (in hours as estimated by JTK_Cycle) and strength of baseline cyclers. Panel C: the phase
distribution of novel recruited cyclers after exposure. Panel D: the co-distribution of phase and
strength of novel recruited cyclers after viral exposure.
2.2.4 Novel gene cyclers are recruited after inoculation
The number of novel recruited cyclers after viral exposure is similar to the number of cyclers in
baseline (1, 964 compared to 1, 884). In Fig. 2.3C and Fig. 2.3D we show the phase and strength
distribution of the novel cyclers. Most of these novel cyclers have Phase 4 or Phase 8, which is
just the opposite of baseline phases. There are only 2 STRONG cyclers, CAT and TLR2. (See
Supplementary Material Fig. 2.16 and Fig. 2.17 for their expression over time.)
Only one pathway, Protein processing in endoplasmic reticulum, is enriched by novel cyclers.
54 out of 129 members in this pathway are novel cyclers only found in post-exposure. This pathway
is not enriched by any baseline cyclers.
Compared to baseline cyclers, these novel cyclers emerged only after inoculation have a smaller
ratio in STRONG and MEDIUM cyclers (4.1% in total cyclers in contrast to 21.7% in all cyclers in
baseline).
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2.2.5 Influence of inoculation on the circadian transcriptome
2.2.5.1 Changes in cycling strength and phase of resilient baseline cyclers
After the disturbance induced by viral exposure, the baseline circadian cycling of some genes
persists (resilient chronotype) while the cycling is quenched for others and fails to persist. Taking
into account the different cycling strength of cyclers, 530 baseline cyclers (28%) successfully
survived the disruption. However, most of them undergo a change in phase relative to baseline.
The effect of viral exposure on cycling strength and phase is shown in Fig. 2.4. We observe, by
comparing Figs. 2.4A and 2.4B, that the distribution of cycling strengths of resilient genes does not
change much; 83% of cyclers still maintain the same cycling strength category (strong, medium,
weak) after inoculation. In contrast the distribution of cycling phases of resilient genes does shift
significantly; from Phase 0 and Phase 20 in baseline, to Phase 4 and Phase 8 after inoculation (Fig.
2.4B).
2.2.5.2 Disruption of baseline-cycling genes is phase-selective
The proportion of baseline cycling genes that retain periodicity for different cycling strength
thresholds depends strongly on the baseline phase. This result is shown in Fig. 2.4C with 6
different strength thresholds ranging from p-value<0.05 (weakest) to p-value<0.000001 (strongest)
computed by JTK_CYCLE. Up to a p-value cutoff at 0.001, there is a consistent phase-selective
quenching pattern of baseline cycling genes. Figure 2.4D redraws this proportion of resilient cycling
genes at p-value cutoff 0.001 in a way that more explicitly reveals the phase-selective quenching
phenomenon. The figure shows that the proportion of resilient cycling genes is minimized at a
phase of 20hrs, corresponding to cycling genes with minimal circadian expression levels occurring
at 8am, near the time of inoculation, and that this resiliency steadily increases as the phase of a
cycling gene approaches 8hrs where the maximum gene expression occurs at 8am.
This finding indicates that a cycling gene presenting its maximal expression level near inoculation
time (8am) has higher likelihood of retaining its periodicity. Conversely, genes presenting minimal
expression levels near inoculation time have higher likelihood of undergoing circadian extinction.
In other words, the phase of a cycling gene at the time of insult determines its circadian resilience.
2.2.6 A biochronicity genotype that differentiates between low and high shedders.
The cohort was divided into two balanced groups of low and high shedders, as explained in
Sec. 2.2.1 (see Fig. 2.1C). Interestingly, there are no significant differentially expressed genes
in baseline between the two sub-cohort groups according to t-test at 0.05 FDR. In contrast, there
is an astonishing difference in their baseline cycling strength. The top 20 genes having largest
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Figure 2.4: Effect of inoculation on baseline circadian rhythm. Panels A and B show the changes in
strength and phase of resilient cyclers remaining rhythmic after inoculation. Panels C and D show
the phase-selective periodicity quenching phenomenon.) Panel A: Changes in cycling strength from
baseline to post-inoculation. Stronger cycling genes are more resilient to viral exposure. Panel B:
Phase distribution of periodic genes in baseline and post-inoculation. While approximately 60% of
cyclers have phase of 20h or 0h in baseline, only 93% of these cyclers shift their phase (to 4h and
8h) after inoculation. Panel C: Proportions of BL cyclers retaining periodicity at different phases
(colored curves) and at different p-value thresholds. Panel D. For a p-value cutoff of 0.001 the
proportions (colored bars at left) of baseline cyclers that retain their periodicity after inoculation are
strongly dependent their phases. Cyclers whose phase maximum occurs near the time of inoculation
(8h) are much more likely to be resilient to inoculation and this resilience decreases as the phase
maximum shifts to other times of day.
baseline cycling strength difference were identified by the ratio in their JTK_CYCLE p-values in
sub-cohorts. The cycling p-value in high shedders of the 20th gene is more than 7, 000 times that
in low shedders. With the exception of phase 4h, we notes that they cover the full range of phases
(0, 4, 8, 12, 16, 20)h reported by JTK_CYCLE. Phase 4 is missing from these 20 genes due to the
fact that there are very few baseline cyclers at phase 4, as reported in Sec. 2.2.3. Gene profiles over
time are shown for low shedders in Fig. 2.5A and for high shedders in Fig. 2.5B. In each subfigure,
the strip at left indicates the cycling status of the gene in BL and PI (red color denotes cycling),
and differential expression of the gene BL to PI (red color denotes differential expression). The
heatmap show the expression levels of the entire time course of these genes. For each gene and each
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Figure 2.5: Heatmaps of a group of 20 BL-cycling genes, ordered by increasing phase, that best
discriminate the low shedders (A) from the high shedders (B) in the challenge study . The 20× 3
strips on the left of the heatmaps denote whether a gene is BL cycling, PI cycling, or differentially
expressed (DR) at FDR level of significance of 0.05 (JTK_cycle test). The heatmaps exhibit the
time courses of gene expression over time from the start of the challenge study to its end. Each
gene is normalized relative to its maximum value. Panel A: for low shedders the 20 genes are all
cycling in BL and 9 are cycling in PI, while none have differential expression in their respective
average levels over BL and PI. Panel B. In contrast to Panel A, for high shedders, only 4 of these
20 genes are cycling in BL and only 1 is cycling in PI. On the other hand, more than half (11) of
these 20 genes are differential expressed from BL to PI. Thus these 20 genes specify a biochronicity
genotype differentiating expression patterns between low and high shedders.
sub-cohort respectively, their expressions were normalized to the range between 0 and 1, so that
cycling and change in expression after inoculation can be visually compared. In low shedders, all
the genes shown in the figure are cycling in baseline, and about half (9 out of 20) continues to be
cycling after inoculation. In contrast, baseline cycling strength is much weaker in high shedders,
with only 4 cycling genes. Only 1 of them, DDIT4, retains cycling after inoculation. DDIT4 is one
of the most significant cycling genes both in BL and PI.
2.3 Discussion
2.3.1 Enriched pathways of BL cyclers and novel post-inoculation cyclers
In order to understand the biological functions of cyclers, a pathway enrichment analysis was
performed, as in Method 2.4. All KEGG pathways were tested, and about 1/3 have been significantly
enriched in baseline cyclers. In the enriched pathways, about 80% of the pathways are related to
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immune system has been targeted. It is known that various immune processes fall under the control
of circadian rhythm, including the regulation of proinflammatory cytokine secretion, trafficking of
myeloid and lymphocyte subsets, differentiation and maturation of clinically important leukocyte
subsets [HAB+20]. Our results confirm the outsized role of immune related pathways in regulating
the healthy basal state which we measured over the 3 day baseline.
Two of the KEGG-annotated Development pathways (Osteoclast differentiation and Axon
guidance) were found to be enriched by the baseline cyclers. It would be intriguing to see whether
there are known connections between development and circadian rhythm. Circadian rhythm has
been previously found to have a role in bone resorption mice[XOF+16]. Furthermore, one gene that
has a role in development, the axon-guidance roundabout gene, was reported to be able to alter the
pace of the Drosophila circadian clock [BBFC08]. Together with our findings that both of the two
development pathways are significantly enriched by baseline cyclers, this may suggest that there
might be a tight bi-directional connection between circadian rhythm and development.
It is of interest that, except for ARNTL that is only a WEAK cycler in our baseline data,
members in the core CLOCK gene modules are not detected as cyclic at baseline in our dataset.
One reason for this may be misalignment of phase: the CLOCK module was not well phase
synchronized across study participants. It is also possible that the whole blood assay used in our
study contains cells masks the CLOCK chronotype due to the phase diversity of circulating blood
cells. Another possibility is that only peripheral tissues are under control of the master clock
in the suprachiasmatic nucleus(SCN). One research group hypothesized that core clocks might
not be necessary in order for in vivo tissues to be cyclic [HCS+14]. Another group identified
many biomarkers for human circadian phase in whole blood that are not classical clock genes or
clock-controlled genes. [LMLP+17].
Only one KEGG pathway, Protein processing in endoplasmic reticulum, has been enriched by
novel cyclers after viral exposure. This is perhaps because most of the novel cyclers are WEAK
cyclers and they distribute evenly from different biological pathways.
2.3.2 Novel recruited cyclers may be critical to launching effective immune response.
Despite the fact that more than 70% of the baseline cyclers ceased to be cyclic after inoculation,
there are almost same number of novel cyclers after viral exposure as the number of all baseline
cycler, just with fewer STRONG and MEDIUM cyclers, as shown in Result 2.2.4.Historically,
circadian rhythm has been expected to be largely lost during severe acute infection [HCS+14]
. However, recently two studies have challenged this idea, claiming that unique sets of novel
cyclers are recruited after infection in LPS-induced endotoxemic mice [HCS+14] and in mice with
tissue-specific disruption of BMAL1 [ZHW+19]. Although it is difficult to compare our novel
cyclers to those discovered in these previous studies, which are specific to species and tissue types,
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our study adds evidence to these findings for the human host. Specifically, our findings suggest that
circadian components recruited after viral exposure could have quite different composition than in
the basal state.
2.3.3 Phase-selective cycling resilience to disturbance
To the best of our knowledge this paper is the first to report such a phase-selective response in
the context of transcriptional disruption of circadian rhythms due to exposure to infection. Other
phase-selective gene responses to intervention treatments have been observed, e.g., chemotherapy
drugs can be more effective if administered at particular circadian phases [SLBG+15]. But such
intervention phase-selectively targets the circadian rhythm of specific tissues, while the mechanisms
governing the influence on circadian rhythm by physiological or pathological environments may be
qualitatively different. The phase-selective cycling resilience and quenching after viral inoculation
merits additional confirmatory study, going beyond the relatively small cohort size and limited
temporal resolution (thrice daily).
2.3.4 Master regulator analysis
It is of great interest to understand the molecular mechanisms that relate the observed immune
response to viral exposure to changes in circadian rhythm. To build understanding, we used a
human transcription factor database TRRUST v2 [HCL+18]. First, a set of 14 genes are identified as
differentially expression from baseline to post-inoculation in full cohort, as well as their transcription
factor relationship is confirmed by correlation analysis This constitutes the immune response module
on the left of the network shown in Fig. 2.6, containing the JAK-STAT pathway at the center. This
pathway is well understood as a primary mediator of the inflammatory response of the immune
system [SL03, VKO17].
Subsequently, transcription factors of cyclers were identified in the same manner, forming the
circadian rhythm module on the right of the network in Fig. 2.6 with NF-κB1 and its subunit RELA
at central positions. NF-κB1 was reported to interact with the core clock protein BMAL1 and to
modify the mammalian circadian clock [SWE+20]. Interim connections connecting the two modules
were discovered from the TRRUST database. The two modules are connected by three paths, each
having two genes(PPARA - NFKBIA; TP53 - BCL3; PML - TNFAIP3). This topological structure
might explain the reason why not all the cyclers from baseline were disabled by the inoculation,
and that NF-κB1 related pathways might be a provide the mechanism for recruitment of novel
cyclers after exposure. This buffering structure reminded us of the regulatory network of E. coli
metabolism, which could demonstrate both homeostasis and flexibility of response. [SJ08]Among
theses buffering genes, NFKBIA, BCL3 and TNFAIP3 belong to the TNF signaling pathway.
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Hepatitis C pathway contains TP53 and PPARA. PML is related to Acute myeloid leukemia and
Influenza A pathways.
Figure 2.6: Master regulator identified with the transcription factor (TF) database [HCL+18] . The
immune response module on the left is comprised of TF-target gene pairs with significantly different
expression from baseline to post-inoculation. JAK-STAT pathway has a central position in this
module. The circadian rhythm module is on the right of the network with NF-κB1 and its subunit
RELA in the center. The two master regulator sets are connected by paths of length two, by finding
all possible paths from STAT1 and IRF1 to NF-κB1 and RELA without rings. This structure in
the transcriptional network might help explain the resilience of certain clock-related genes and the
emergence of circadian rhythm in other genes after inoculation.
2.3.5 Difference in baseline between sub-cohorts
Our discovery that cycling strength differ in low shedders and high shedders suggests potential
markers of infection susceptibility. The set of genes have similar mean expression levels over BL
and PI but differ in the strength of their chronotypes. For the molecular states we have shown in Sec.
2.2.6 that the weakness and instability of the circadian cycling genes over baseline that differentiates
the severely infected subjects from the others . Markers of association are not necessarily indicative
of risk factors, so more work is needed to establish if these associations reflect causal relationships
or not. Future experiments with larger cohort size, longer baseline and higher temporal sampling
resolution would allow us to confirm these findings.
2.3.6 Limitations
Our findings provide interesting perspective on circadian rhythm of blood transcriptome and the
interaction between circadian rhythm homeostasis and viral infection. It would be interesting to
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perform follow up experiments to further validate our observations. For example, we found that
many baseline cyclers are involved in immune related pathways. This is possibly due to the fact
that this study took human whole blood as the biological sample, where leukocytes are a major
component. It could provide more information if we can combine flow cytometry and RNAseq,
which could enable us to examine the circadian rhythm of each cell type or specific cells of interest
in human whole blood.
In addition, we observed the phenomenon of phase-selective baseline cycler extinguishment.
But with the entire cohort inoculated at the same time of day, it remains unknown whether this
phase-selective quenching is based on time of day when the cyclers peaks occur and invariant to
inoculation time, or based on the relative distance between the acrophases of cyclers and inoculation
time. Additional experiment with inoculations at different time of day may help elucidate this
question. If the latter is true, circadian rhythmicity in disease susceptibility may be due to different
groups of baseline cyclers are quenched following inoculation.
Limited by the number and frequency of samples, we could only identify significantly cyclic
genes on a population / sub-population level, which prevented us from building a predictive model
to estimate infection susceptibility with individual baseline cycling strength.
2.4 Materials and Methods
Challenge study A human viral challenge (HVC) study was performed with human rhinovirus
(HRV) in 2015 at the University of Virginia. A total of 24 volunteers were recruited and 19
participated completed the study. One of these participants had a failed inoculation and was omitted
from our analysis.
The age range of the remaining 18 participants was between 18 and 33, two thirds of these
participants were male, and 4 were non-caucasian. The demographics of the 18 individuals included
in our analysis is shown in 2.7.
The study was reviewed and approved by the Institutional Review Boards at Duke University and
at University of Virginia . Written informed consent was obtained from all participants. Exclusion
criteria included pregnancy, chronic respiratory illness, high blood pressure, tobacco/drug/alcohol
history, and serum antibody levels above 1:4 titers. The participants were not isolated during the
study.
The challenge study lasted 9 days over which various types of biomarkers were continuously
collected from participants using wearable wristbands (Empatica E4), whole blood assays (mRNA,
p180 metabolites, steroids), nasal-pharyngal washes (viral shedding), cognitive testing (Lumos),
and self-reported clinical data (symptoms). On day four at 8am (denoted as 0 hours in this paper)
each participant was inoculated via intranasal drops of diluted Human Rhinovirus strain type 16
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with a dose of 100TCID50 in 1mL Lactated Ringer’s Solution.
Their molecular, physiological, hormonal and cognitive samples were collected both before and
after the exposure of HRV. After inoculation, the participants underwent daily nasal lavage each
morning to determine the amount of viral shedding and a cumulative shedding score was computed
by summing up each person’s shedding titrations over the post-inoculation period. The modified
Jackson Score requires subjects to rank symptoms of upper respiratory infection (coughing, sore
throat, sneezing, headache, etc) on a scale of 0 – 3 of "no symptoms", "just noticeable", "bothersome
but can still do activities" and "bothersome and cannot do daily activities". Self-reported symptom
scores were also recorded and a cumulative modified Jackson score was computed using the formula
described in the section entitled "Case Definitions" in [ZCV+09a].
RNA-seq pre-processing The mapped count data was transformed into TPM (Transcripts per
million)[WKL12] for further analysis.
Periodicity estimation The periodicity of all biomarkers were tested following the standard
protocol of JTK_CYCLE method [HHK10]. The p-values are adjusted to false discovery rate for
multiple testing.
Pathway enrichment analysis The Fisher Exact Test (FET) was used to assign the level of
significance (p-values) to the overlap of gene set of interest and 329 pathways in the KEGG database
[KGK+04] respectively. The p-values are adjusted to false discovery rate to account for multiple
testing.
Master regulator analysis A transcription factor database [HCL+18] is employed to discover
the regulatory relationships in gene sets. For a given gene list, all upstream transcription regulators
are identified. With all these pairs, a gene network can be visualized in Cytoscape.
2.5 Conclusion
We presented an analysis of biochronicity of a spectrum of biomarkers collected from a human
bio-longitudinal viral challenge study. The temporal evolution of these biomarkers fell into several
chronotypes with different patterns of circadian cycling in the basal state (baseline) as contrasted
to post-inoculation. Many baseline gene expression cyclers are associated with immune response
pathways. Although some baseline cyclers maintained their periodicity after inoculation, many
of these underwent a shift in cycling phase and strength. In addition, novel cyclers emerged after
inoculation. Some baseline cycling genes selectively undergo phase-selective quenching and those
that attain minimum cycle amplitude nearer the time of inoculation are more likely to lose periodicity.
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The baseline cyclers are more numerous and much stronger in low shedders than in high shedders.
Using a transcription regulation analysis on the circadian and differentially expressed genes, we
proposed a buffered network mechanism that mediates between the immune response, governed by
the JAK-STAT pathway, and the circadian module, governed by the NF-κB signaling pathway and
RELA. The two master regulators are buffered by a small number of genes, which may play a role
in ensuring resiliency and emergence of novel circadian cycling after inoculation.





Demographics of Volunteers in Human Viral Challenge A table of demographics of volunteers
in this challenge study is shown in Fig. 2.7.
Low shedder High shedder Total
Median Age (range) 21 (20-24) 20 (19-33) 20(19-33)
Gender
Male 8 4 12
Female 1 5 6
Ethnicity
White 7 7 14
Black 2 0 2
Asian 0 2 2
Dominant hand
Right 9 9 18
Left 0 0 0
Median Systolic BP (range) 120 (100-130) 110(100-120) 112(100-130)
Median Diastolic BP (range) 70 (60-80) 70 (58-79) 70 (58-80)
Median Pulse (range) 64 (60-72) 72 (60-80) 67 (60-80)
Median Respiratory Rate (range) 20 (16-20) 18 (16-20) 19 (16-20)
Median Weight (range) 71 (61-89) 65 (55-73) 67 (55-89)
Getup time
before 6:30 0 1 1
6:30-7:45 1 0 1
7:45-9:45 5 6 11
9:45-11 3 1 4
11-12 0 1 1
Bed time
10:15-12:30 5 5 10
12:30-1:45 4 2 6
1:45-3 0 2 2
Productive time
Morning 4 3 7
Afternoon 3 1 4
Evening 2 3 5
Night 0 2 2
Figure 2.7: Demographic distribution of the 18 subjects included in the analysis of the viral
challenge study.
Time courses of shedding and symptom Time courses of shedding and symptom are shown in
Fig. 2.9.
Relationship of accumulated shedding and accumulated symptom Accumulated shedding
and accumulated symptom are linearly correlated, with a Pearson correlation of 0.82 and p-value
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Histogram of inocculation times
=8am
Figure 2.8: Histogram of the inoculation times for the 18 participants. Eighty hours corresponds
to 8am on the morning of the 4th day of the challenge study. All but 2 participants are inoculated
between of 7 and 9am.
3.28−5, 95% Confidence Interval at [0.57, 0.93]. The scatter plot is shown in Fig. 2.10. The
accumulated symptom scores is also shown in Fig. 2.11. They are ordered by increasing total
shedding levels from left to right. All high shedders have more severe symptom than low shedders
except for participant 19.
Definition and illustration of cyclers with different strength Definition of cycling strength
categories: We measure strength of cycling of a biomarker using the level of significance of the
JTK_CYCLE periodicity test. For each biomarker time course tested JTK_CYCLE outputs a
Benjamini-Hochberg FDR p-value or, in the case that there are too few unique values in the time
course, a "Fail". We consider any biomarkers that "Fail" as non-cycling. We define 4 different
cycling strength levels as follows:
• Strong cycling have smallest BH-Q: FDR ≤ 10−6
• Medium cycling have smaller BH-Q: 10−6 ≤ FDR ≤ 10−3
• Weak cycling have small BH-Q: 10−3 ≤ FDR ≤ 0.05
• Non cycling have large BH-Q: 0.05 < FDR
These three types of cyclers are illustrated in Fig. 2.12.
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Figure 2.9: Shedding and symptom data for the 18 subjects in the cohort. A-B: Shedding heatmap
(A) and shedding curves (B) over the full timecourse of the challenge study. C-D: Symptom heatmap
(C) and symptom curves (D), where symptom is a aggregate of 8 different symptoms computed as a
modified Jackson score. All subjects exhibit a detectable amount of post-inoculation viral shedding.
All subjects except for Subject 6 complained of symptoms.
STRONG cyclers A list of all STRONG cyclers are shown in Fig. 2.13 and Fig. 2.14
Gallery of biomarkers Time course and periodogram of some biomarkers mentioned in the





































Figure 2.10: The linear correlation between accumulated shedding and accumulated symptom.





































Figure 2.11: Accumulated symptoms of participants ordered by increasing total shedding levels
from left to right. All high shedders have more severe symptom than low shedders except for
participant 19.
Figure 2.12: Illustration of biomarkers that cycle with different circadian cycling strength levels.
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Figure 2.13: Circadian biomarkers cycling over baseline found to be statistically significant using
JTK_CYCLE analysis. The cyclic phases of these circadian biomarkers (in hours in 3rd column
of each category) are indicated. Only biomarkers with FDR significance level less than or equal
to 0.000001 are shown. A total of 63 biomarkers are discovered with p-values under the FDR
threshold (denoted BH.Q in the Table) including: 45 genes; 7 p180 metabolites; 2 hormones; and 9
E4 features.
Figure 2.14: Circadian biomarkers cycling over post-exposure period found to be statistically
significant using JTK_CYCLE analysis. The cyclic phases of these circadian biomarkers (in hours
in 3rd column of each category) are indicated. Only biomarkers with FDR significance level less
than or equal to 0.000001 are shown. Note that there are substantially fewer strongly cycling
biomarkers than at baseline 2.13.
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Figure 2.15: Time course of DDIT4, and periodogram in baseline and post viral exposure.
Figure 2.16: Time course of CAT, and periodogram in baseline and post viral exposure.
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Figure 2.17: Time course of TLR2, and periodogram in baseline and post viral exposure.
Figure 2.18: Time course of cortisol, and periodogram in baseline and post viral exposure.
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Figure 2.19: Time course of melatonin, and periodogram in baseline and post viral exposure.
Figure 2.20: Time course of DHEAS, and periodogram in baseline and post viral exposure.
36
CHAPTER 3
Adaptive Sleep Detection and Physiological Features for Infection State and
Onset Prediction
3.1 Introduction
Many physiological time series involve dynamic transition among event states. For example,
the transitions in human circadian cycling alternate between sleep and wake states over a 24-hour
period. The sleep state can itself be a dynamic process, switching over different stages of rapid
eye movement (REM) and non-REM sleep states [CD+05]. As another example, the transitions in
menstrual cycles go through follicular and luteal phase [SOG+10], transitioning to an ovulation state.
With the emergence of cheap wearable multi-channel physiological monitoring devices, there has
been much interest in automating the detection of physiological event states. The potential impact
of automated event detection is far reaching, potentially improving a person’s health awareness and
aiding the management of disease.
A principal impediment to automating event detection for wearable devices is the intrinsically
high variability of the measured physiological signals over time. An especially challenging situation
is when the wearer of the device undergoes a strong perturbation, such as exposure to a pathogen
that results in infection. Most event detection algorithms that are trained over a healthy baseline
time period will have difficulty adapting when the device’s signals become strongly perturbed
away from baseline. Modern machine learning approaches to training that incorporate transfer
learning can mitigate these difficulties. This paper introduces an adaptive transfer learning method
for automating event detection for wearable devices and demonstrates its ability to adapt to strong
perturbations from a healthy baseline in the context of a human viral challenge study.
Another challenge to automating event detection in time series data is the lack of available
ground truth event labels. The training of the automated algorithm must thus be unsupervised,
based only on the observable physiological signals measured by the device. Effective unsupervised
learning is only possible when features extracted from these signals have statistical distributions that
strongly depend on the event states. Selection of strong discriminating features is therefore a crucial
step in designing an unsupervised learning algorithm. The adaptive transfer learning algorithm
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introduced here generates a set of strongly discriminating event-labeled features that are based on
statistical summaries of the device signals at multiple time scales.
A state-of-the-art unsupervised algorithm for detecting unobserved event state sequences from
time series data is the hidden Markov model (HMM) [ZML17]. The HMM is a generative model in
which the hidden states are latent random variables that condition the joint probability distribution of
the data. HMM methods have been widely applied to many health applications [BKN17, KMB+10,
Yu12, TMC+13, BDTH12]. However, the HMM is not well adapted to data whose statistical
distribution may shift over time. When there are external factors that cause perturbations to the
distribution, the training data may be mismatched to the post-training data and the HMM will fail to
perform as well as expected. In the machine learning literature this phenomenon is known as data
covariate shift [MTRAR+12]. Many methods have been proposed to address the covariate shift
problem, principally for supervised learning [WK96, KJ00, KŽ09, PY+10, GŽB+14].
The adaptive unsupervised transfer learning method for event state classification introduced in
this paper is designated by the acronym HMM-FLDA. It involves learning a multivariate HMM latent
state prediction model that initializes a sequential version of Fisher’s linear discriminant analysis
(FLDA) to adapt the initialized HMM to perturbed post-baseline data. Our adaptive transfer learning
method is introduced as the key component of a complete data processing pipeline that includes pre-
processing for local feature extraction and abnormal signal detection, adaptive event classification
using HMM-FLDA, and post-processing for constructing strong high dimensional event-labeled
features for inferring perturbation-dependent events, e.g., health outcome after exposure to a viral
pathogen.
We illustrate the proposed analysis pipeline for a human viral challenge (HVC) experiment
in which physiological data from multiple subjects is collected over multiple days from wearable
wristband devices. On the second day of the experiment the subjects were exposed to a H1N1 flu
virus that caused some to become infected, as clinically determined by viral shedding which does
not occur before the 4th day. For each subject, the HMM-FLDA is trained on the first two days and
nights of wearable data to generate sleep/wake features. Using these features we are able to predict
if the subject will get infected and the onset time, defined as the first day that shedding is detected.
The remainder of this paper is organized as follows: we introduce in detail the proposed transfer
learning algorithm in Section 3.2. Section 3.3 presents a numerical simulation study emulating
the HVC experimental data, but with ground truth event labels. Section 3.4 applies the proposed
analysis pipeline to wearable data collected in the experimental HVC study. In Section 3.5 we end
the paper with discussion and conclusions. Supporting information on the algorithm, the pipeline,
and the HVC data is presented in the supplementary Appendices.
38
3.2 Adaptive unsupervised event monitoring
Figure 3.1a summarizes the proposed adaptive event labeling procedure and Algorithm 1
provides pseudo-code for its principal steps. Figure 3.1b shows the entire data processing and
analysis pipeline, from sensor data capture to event-labeled feature extraction to predictive models
using these features.
Algorithm 1 HMM-FLDA gradual self-training event state classifier
1: Initialize with: {ŷt,xt}
tN0
t=1 . Use HMM to classify baseline data
2: while tN0 < t < tN do . Continue over all batches of samples
3: for l in 1 to L do . Iterate over candidate training sizes dl
4: procedure FISHER’S LDA(train = (t− dl, t], test = (t, t+ ∆t])
5: w = S−1W (x̄1· − x̄0·) . Update FLDA weights on train data
6: zt = w
Txt
7: ŷt(dl) = 1
{
(zt − z̄0·)2/σ̂20 − (zt − z̄1·)2/σ̂21 > log(γ σ̂21/σ̂20)
}
. Classify test data
with updated weights
8: SI(dl) = SI(train, test; dl) . Compute separability index (3.5)
9: d(1) = which.max(SI(dl)) . Select optimal training window length
10: ŷt = ŷt(d(1)) . Classified labels of current batch
11: t = t+ ∆t . Move on to the next batch
The pre-processed data comes in the form of a p×N matrixX = [xt1 , . . . ,xtN ] where xt ∈ Rp
is a p-dimensional real valued feature vector, available at a set of time instants {ti}Ni=1. We assume a
statistical time series model for xt with hidden states that determine the joint probability distribution
pX(x1, . . . ,xN). Specifically, associated with each time sample xt is a latent (hidden) variable
yt ∈ {0, 1, . . . , K}, which labels the event associated with xt. Later in the paper we will specialize
to the binary case where K = 2 and the events correspond to a person’s sleep or wake state at
a particular time. We denote y = [yt1 , . . . , ytN ] the time sequence of a subject’s hidden event
states. In the time series setting, y determines the conditional probability distribution pX|y and
the marginal probability distribution pX . We construct an event classifier function based on an
HMM with a parametric (Gaussian) conditional distribution of xt given yt that may gradually shift
over time, e.g., due to a perturbation after exposure to a pathogen. The parameters of the classifier
function are estimated from the data in a two phase process involving: (1) an initial training phase
where the HMM model is fitted to a batch of (healthy) baseline data, followed by (2) an adaptation
phase where a naive Bayes Gaussian model is adapted to future batches of possibly perturbed data






















Figure 3.1: (a) The proposed HMM-FLDA unsupervised transfer learning algorithm based on a
multivariate hidden Markov model (HMM) and Fisher’s linear discriminant analysis (FLDA) to
segment event states; (b) The three stages of proposed data processing pipeline, discussed in Section
3.4.1. The HMM-FLDA procedure depicted in (a) appears in the second stage of the pipeline.
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3.2.1 Baseline training: HMM initial segmentation
For N0 < N define the baseline (BL) segment of the data X as the first N0 time samples
XBL = [xt1 , . . . ,xtN0 ] and the post-baseline (PBL) segments of the data as the remaining part
XPBL = [xtN0+1 , . . . ,xtN ]. The BL segment is used as a training set for learning the parameters
of a multivariate HMM [VS+10]. The HMM is a Markov model: modeling the observations as
an N -length segment of a Markov random process {(xt, yt)}∞t=−∞, where transitions yt−1 → yt
between event states have probabilities specified by a K ×K state transition matrixA. The Markov
property implies that the joint distribution pX,y factorizes as: pX,y = pxt1 ,yt1
∏N0
i=2 pxti ,yti |xti−1 ,yti−1 ,
implying an analogous factorization of the marginal pX and the conditionals pX|y. In the special
case of a Gaussian HMM model each factor pxt|yt is a multivariate Gaussian conditional distribution,
denoted as
xt | (yt = k) ∼ N(µk,Σk), k = 1, . . . , K, (3.1)
where µk is a p-dimensional mean parameter and Σk is a p× p covariance matrix parameter that
must be learned in addition to the state transition matrixA.
There are several methods available for learning multivariate HMM’s [GS11, ZML17] which
could be adapted to our setting. Most methods are iterative and many use a variant of the expectation-
maximization (EM) algorithm to find maximum likelihood estimates of the unknown parameters.
Important practical considerations are whether the HMM algorithm provides a final estimate of
labeling accuracy, important for self diagnostics, if it converges sufficiently rapidly to a global
maximum, and if it has fast computation time per iteration, which tends to increase as K and p
increase. In some applications, it may be desirable to estimate the number of event states K, for
which automated model selection versions of HMM are available. For a comprehensive review of
HMM implementations the reader can refer to [ZML17, Ch. 8]. In our pipeline we use a reasonably
fast multivariate HMM algorithm implemented by EM iterations that approximates the maximum
likelihood estimator of the HMM parameters. In the Expectation (E) step, the marginal likelihood is
computed by a variant of the forward-backward algorithm [LH02], which calculates the gradient of
the log-likelihood (score) function in a single pass.
3.2.2 Post-baseline adaptation: sequential transfer learning
If the feature distribution varies over time, the static baseline-trained HMM will have difficulty
classifying and segmenting events in the post-baseline data XPBL. To address this difficulty we
introduce a transfer learning strategy that is initialized with the HMM on the initial-training data and
sequentially updates the event classifier over successive batches of test data, continually adapting to
changes in distribution. In transfer learning the batches are called target domains and the objective
is to design a classifier that continually adapts to them, a property called domain adaptation [KF11],
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[MTRAR+12]. To achieve this objective, we use an unsupervised gradual self-training procedure.
In supervised transfer learning, “self-training" means that domain adaptation is done with an
unlabeled test set and “gradual" means that the adaptation is done sequentially over time, updating
over successive batch pairs. As compared to direct self-training procedures, which try to adapt to all
test batches at once, gradual self-training procedures are better suited to online applications and
are more robust to smoothly varying shifts in distribution. Recent theory establishes that gradual
procedures are provably better when the class distributions on successive pairs of batches are close
in Wasserstein distance [KML20]. This closeness condition is satisfied when the distributions are
quasi-stationary, an assumption common in time series analysis [Ada98] and online supervised
learning [SS+12].
Our unsupervised gradual self-training procedure consists of three components: 1) an unsuper-
vised version of Fisher’s LDA that uses class labels predicted by the HMM to project the dataXBL
to a one dimensional space that maximally separates these classes. 2) application of this projection
to the next batch of samples inXPBL followed by event classification using a naive Bayes classifier;
3) using the class labels to update the projection by reapplying Fisher’s LDA to the batch filtered by
a tapered sliding-window. This process is sequentially repeated for each successive batch, resulting
in a continuous adaptation of the event classifier.
Fisher’s LDA is most commonly applied in the context of supervised learning for dimension
reduction and classification [Fis36, FHT01] when a labeled sample is available for training. Here
we adapt LDA to the unsupervised context of latent event classification. After applying HMM to the
baseline sample xt1 , . . . ,xtN0 we obtain estimated class labels ŷt1 , . . . , ŷtN0 . We then train Fisher’s
LDA classifier on the putatively labeled sample {(xt1 , ŷt1), . . . , (xtN0 , ŷtN0 )}. Fisher’s LDA uses
dimensionality reduction to learn a classifier. By applying a weight w ∈ Rp to xt FLDA generates
a projection score zt = wTxt. The weight vector is optimized so that these scores attain the largest
possible separation of the classes. Fisher’s LDA accomplishes classification of a novel sample xt′
by using the trained weights to compute the projected score wTxt′ that is used in an optimal naive
Bayes LDA classifier to predict its unknown label yt′ .
Specifically, for the case of K = 2 classes yt ∈ {0, 1}, in the dimensionality reduction stage of
FLDA the class separability of the projection scores zt = wTxt is measured by the following ratio
of between-class variation and within-class variation:
J(w) =
(z̄1· − z̄)2 + (z̄0· − z̄)2∑




where Gk = {t ≤ N0 : yt = k} denotes the data indices of xt coming from event class k,
z̄k· = |Gk|−1
∑
t∈Gk zt for k ∈ {0, 1} are the class-specific sample mean projected score and z̄ is
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the overall sample mean projected score. The optimal w that maximizes (3.2) is [FHT01]
w = S−1W (x̄1· − x̄0·), (3.3)
where x̄k· = |Gk|−1
∑





x̄k·)(xt − x̄k·)T is the within-class scatter matrix of the xt’s.
Under the multivariate normal model (3.1) forxt, the zt’s are conditionally independent Gaussian
distributed random variables with conditional mean µk and conditional variance σ2k given yt = k.
Assuming independent conjugate priors on µk and σ2k, conditioned on the training data XBL, the
maximum a posteriori (MAP) estimator of the class label yt′ of a novel test sample xt′ based on its















where 1(A) is the binary indicator function equaling 1 when the logical preposition A is true.
Here, as above, z̄k is the class-specific sample mean and σ̂2k the within class sample variance of
{zt : t > N0} σ̂2k = (|Gk| − 1)−1
∑
t∈Gk(zt − z̄k·)
2. The threshold parameter γ in (3.4) is the prior
odds ratio P (yt′ = 0)/(1− P (yt′ = 0)) and can be adjusted to account for class imbalance and to
trade-off the two types of classification errors. The naive Bayes classifier classifies the label of the
test sample based on its relative distance to each of the class centroids z̄k weighted by the class
dispersions σ̂2k.
We next describe the proposed unsupervised transfer learning procedure using gradual self-
training to sequentially update the HMM-FLDA algorithm as, outlined in Algorithm 1 and depicted
in Fig. 3.1a. The post-baseline data is successively divided into disjoint test batches of length ∆t
secs., called the test window length, a tuning parameter whose selection is application dependent.
The current batch is used as a test sample to update the self-trained HMM-FLDA classifier de-
termined from the previous batch. Let ttstn = t
tst
n−1 + ∆t be the start time of the n-th test window
and denote the n-th test batch as Ttst = {xti}ti∈[ttstn ,ttstn +∆t). The update proceeds as follows. For
a specified size d, define the n-th training set Ttrn = {xti}ti∈[ttstn −d,ttstn ). Note that the feature
instances in Ttrn have already been assigned class labels {ŷti}ti∈[ttstn −d,ttstn ) in the previous update
of HMM-FLDA. Hence, the first step in updating the classifier is to compute the updated FLDA
weight vector w, as defined in (3.3), using Ttrn and its previously assigned class labels. The second
step is to use this updated weight vector to assign predicted labels {ŷti}ti∈[ttstn ,ttstn +∆t) to instances in
Ttst.
The size d of Ttrn is adapted from batch to batch by optimizing a separability index (SI) defined
over Ttrn ∪ Ttst. Among the many possible SI measures that could be used, we adopt Thornton’s SI
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[Tho98], a competitive measure for assessing class separation originally introduced for supervised
classification problems [AR07, CMS12, Gre01]. Also called the geometric separability index
(GSI), Thornton’s measure has seen wide application in health, robotics, geology and other fields
[MR10, CL14, SR14, TMN10, RWM15]. We use the following simple unsupervised modification
of the GSI [Tho98], computed on the merged training and test samples for the batch:
SI(d) =
∑
t∈Ttrn(d)∪Ttst{ŷt + ỹt + 1}MOD 2
|Ttrn(d)|+ |Ttst|
, (3.5)
where ỹt is the predicted class of the nearest neighbor of xt in the set of merged training and test
samples. As compared to Thornton’s original SI, defined for supervised classification problems
where the true labels yt are known, the unsupervised modification (3.5) uses the predicted labels
ŷt in place of yt. Here the nearest neighbors are determined by the “projection distance” defined,
for samples at time t and t′, as d(t, t′) = |ŵT (xt − xt′)|. Rank ordering the SI indices SI(d(1)) >
. . . > SI(d(L)) yields d(1) as the optimal training window length for the batch.
3.3 Numerical simulation study
We performed a simulation of HMM-FLDA that emulates the experimental study presented in




t ] is simulated
from conditional distributions given the latent event state yt, which randomly switches between
wake (yt = 0) and sleep (yt = 1) with a mean cadence of approximately 24 hours. To emulate the
perturbation effect of viral infection, each of these conditional distributions are fixed during the
baseline training period but may undergo slowly varying time shifts in the post-baseline period.
Two different post-baseline scenarios are simulated, called the stable case (no shift) and the unstable
case (slow shift).
For the stable case, we generate the sequence of states as a realization of a Markov process
with state transition probabilities that are empirically matched to those extracted from the HVC
data described in the next section. We fix the number of state transitions T and the initial state is
set to y0 = 0. The duration ∆τ1, i.e., the time to the first transition, is drawn from TN(µ0, σ0), a
truncated normal (TN) distribution with location and scale parameters µ0 and σ0. The duration ∆τ2
of the second event is independently drawn from a TN distribution with mean µ1 = 24− µ0 and
variance σ21 = σ
2
0 . This process is repeated until the T -th transition variable ∆τT has been drawn.
The discretized transition times τm =
∑m
i=1 ∆τi, m = 1, . . . , T , specify the state sequence {yt, t =
1, . . . , N}. A consecutively occurring pair of (wake, sleep) periods is called a session. Over a given
session m, the data channels x(i)t , i = 1, 2, were drawn independently from a truncated normal




k ) and a log-normal distribution p(x
(2)
t |yt = k)
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of the form LN(u(2)k , σ
(2)
k ), whose translation and scale parameters u and σ depend on the state
k = 0, 1. These two distributions emulate the median heart rate feature and the accelerometer
standard deviation feature used in Section 3.4.2.2 for the full time course HVC data.
For the unstable case, the parameters of the distributions of yt and xt were changed from session
to session to reflect perturbations during the post-baseline period. Specifically, the truncated normal
parameters (µmk, σmk) of the event durations ∆τm were made to be session dependent by matching
these parameters to the empirical distributions of the HMM-FLDA estimated duration for the m-th
session, where the empirical distribution was constructed over the sub-population of symptomatic
subjects in the HVC study. Furthermore, we introduced a time-varying post-baseline conditional
mean u(i)mk = E[x
(i)
t |yt = k] of the i-th channel over the m-th session for the k-th event state. In
particular, the post-baseline conditional mean was modeled as a quadratically varying function





2 / (1−mo)2 + b(i)k , for m = 1, . . .M, i = 1, 2, k ∈ {0, 1}.
Here mo is the index of the session where the mean u
(i)






− u(i)1k is the difference between the apex value u
(i)
mok
and the initial value u(i)mk. The
pair (mo, b
(i)




t ) change over sessions. In the simulation,
mo was randomly drawn from {5, 6, 7} with equal probability, and we considered 2 sets of values
for the b(i)k ’s. To achieve a close facsimile to the experimental data analyzed in Section 3.4, we
simulated M = 11 sessions, and the time between samples was set to δt = 1/6 hr, i.e., the 10
minute aggregated sample period used in that section. Furthermore, all of the translation and
scale parameters used in the simulation were matched to summary statistics obtained from the
HMM-FLDA analysis described in Section 3.4.2.2. Several realizations of the simulated data are
shown in Fig. 3.5 in the Appendix.
Table 3.1: Out of sample performance of the proposed adaptive transfer learning algorithm as
compared with standard HMM operating on the original data (HMM) and operating on LOESS
detrended data (dHMM).
Setting Methods Accuracy F1 Cosine dis. Onset diff. Duration diff.
stable HMM 0.9981 0.9987 0.9968 0.0165 0.0307
dHMM 0.9981 0.9986 0.9967 0.0253 0.0373
Proposed 0.9980 0.9986 0.9964 0.0168 0.0313
unstable++ HMM 0.8959 0.9209 0.8559 1.6704 2.9169
dHMM 0.9127 0.9231 0.8957 2.4709 2.2653
Proposed 0.9356 0.9544 0.8904 1.0679 1.5756
unstable+- HMM 0.9369 0.9510 0.9187 0.2763 1.9750
dHMM 0.9271 0.9370 0.9114 1.0170 2.0131
Proposed 0.9758 0.9833 0.9564 0.3712 0.3817
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Table 3.1 compares the empirical performance (a total of 1000 independent trials on 100 different
realizations of the model) achieved by the proposed HMM-FLDA procedure to other procedures
(HMM and dHMM) for the stable and unstable cases described above. Each of the stable and






1 ) that define
the trend in the post-baseline mean u(i)mk. For a stable subject there is no mean trend for either
event class and all of these coefficients are zero. Two unstable cases are considered: a case called
unstable++, where the trends for both event classes are concave with a randomly located peak, and
a case called unstable+-, where for each event class the trends go in opposite directions, i.e., one
trend is concave while the other is convex. The table shows the value of 5 performance criteria
(averaged over 1000 independent trials) when the method is trained on a single realization of the two
signals and tested on an independent out-of-sample realization drawn from the same distribution.
The performance criteria are:
• Accuracy: the number of samples with correctly classified event states divided by the total
number of samples,
• F1: the harmonic mean of the precision and recall classification criteria,
• Cosine dis.: the cosine distance between the vector of classified event states and the
ground truth states,
• Onset diff. the absolute difference between estimated onset time of a sleep session and
the nearest onset time of a true sleep period, averaged over sessions,
• Duration diff. the absolute difference between estimated duration of a sleep session
and the duration of a true sleep period that overlaps with the predicted one, averaged over
sessions. (If the predicted period doesn’t overlap with any true period, the difference is taken
as the length of the predicted period)
Table 3.1 compares the mean performance of the proposed method to a standard off-the-
shelf two-state HMM state estimator and a variant of HMM, called dHMM, that uses locally
estimated scatterplot smoothing (LOESS) [Cle79] to detrend each of the two data channels as a
preprocessing step before training the HMM. The HMM and LOESS were implemented with R
packages depmixS4 [VS+10] and fANCOVA. The results shown in Table 3.1 establish the benefit
of our proposed HMM-FLDA adaptive procedure. In terms of event classification performance
(Accuracy, F1, and Cosine distance), except for cosine distance in the unstable++ case, where
the performances are statistically equivalent, the proposed method significantly outperforms the
competing HMM and dHMM procedures for both unstable++ and unstable+- models (p-value
0.01 according to one-sided paired t-test). It is also worth noting that, in the unstable++ case,
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LOESS detrending of dHMM improves on HMM across all criteria except for onset diff., which
is the r.m.s. estimation error for sleep onset time. The Supplementary Appendix 3.6.3 provides
additional details on this simulation.
Table 3.2: Parameter settings for the HVC data processing pipeline
Symbol Value Description Loc. in pipeline
δt 10 minutes epoch length local feature extraction (pre-processing)
t1 Hour 0 starting time of BL segment Baseline HMM training
tN0 Hour 36 end time of BL segment Baseline HMM training
∆t 3 hours test window length Domain adaptive FLDA training
dl {12, 13, . . . , 59, 60} hours training window lengths Domain adaptive FLDA training
γ 1 prior odds ratio Domain adaptive FLDA training
3.4 Application to HVC experimental data
We apply the proposed adaptive transfer learning method to sleep/wake event classification for
an experimental dataset undergoing a perturbation after baseline. This dataset of wearable data was
collected as part of a human viral challenge (HVC) study where data from a cohort of participants
was collected before and after exposure to a viral pathogen. More details on the HVC study are
provided in Appendix 3.6.1. We will show that the proposed FLDA-HMM algorithm, trained
individually on each participant without clinical outcome data, is capable of segmenting sleep events
and extracting features that can be used to accurately predict clinical outcomes, specifically whether
a subject is infected or not, and the onset time of infection.
Sleep has repeatedly been found to be associated with immune, cardiovascular, and neuro-
cognitive function [Mil15, Irw15], among other functions. Many studies have revealed that changes
in sleep pattern can be an important modulator of human response to diseases. For example, in
a human viral challenge (HVC) study [DRR+00], researchers found that nasal inoculation with
rhinovirus type 23 significantly reduced total sleep time among symptomatic individuals during the
initial active phase of the illness. In another study [CDA+09], shorter sleep duration in the weeks
preceding an exposure to a rhinovirus was found associated with lower resistance to illness. Since
physiological signals such as instantaneous heart rate, physical activity, and skin temperature differ
substantially during wake and sleep periods, automated sleep/wake labeling is possible. Therefore,
the development of effective sleep monitoring methods has been of increasing interest.
While polysomnography (PSG) is the gold standard for sleep monitoring in sleep-related studies
[KHH+17, DRS18], it is often cumbersome outside of a lab setting as it uses electroencephalogram
(EEG), electrocardiogram (ECG), and electromyogram (EMG), and requires a registered technician
to perform sleep scoring [RK]. Recently much effort has been made to remedy the inconvenience
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of manual scoring and, alternatively, to provide automated analysis of the PSG signals [FDSR02,
MYK+13, KDM+18]. Thus there has been growing interest in low-cost alternatives to PSG using
small package wearable devices. Signals captured by wearable sensors have included movement
induced accelerometer signals, circulating blood volume pulse (BVP), heart rate (HR), electrodermal
activity (EDA), temperature, respiration effort (RSP), ambient light and sound. These devices can
be wrist-worn, ankle-worn, arm-worn, lapel-worn, chest-worn or embedded in mobile phones
[KMF08],[SCS+17], [DRS18]. The Empatica E4 device (Empatica Inc. USA), used in the HVC
study discussed below, captures 4 such signals.
WAKE session SLEEP session








Figure 3.2: Labeling of events and event sessions from wearable data, illustrated for one of the
features (HR MED = heart rate median) and one of the meta-features (HR MED.sd = standard
deviation of HR MED) for Empatica E4 device in the Human Viral Challenge (HVC) study. In
the first stage of the pipeline in Fig. 3.1b, epochs of 10 min duration (δt in Table 3.2) are used as
windows over which temporally localized statistical features (mean, median, standard deviation) of
the E4 device signals are extracted. These features are used in the second stage of the pipeline that
extracts event labels, wake and sleep in the case of the HVC, and organizes them into contiguous
labeled time segments, called sessions. In the third stage of the pipeline event-labeled meta-features
(HR MED.sd (wake) and HR MED.sd (sleep)) are extracted as statistical summaries over the wake
and sleep sessions.
3.4.1 HVC data and processing pipeline
Data was collected from E4 wristband devices worn by 25 participants enrolled in a longitudinal
human viral challenge (HVC) study over the time period: 0 hours to 270 hours (11 days). The
study participants were exposed to a pathogen (Inf H1N2) on the second day of the study at
36 hours (noon on day 2). Over subsequent days some participants developed symptomatic
infection, confirmed by viral shedding from PCR assay on nasal lavage once per day. Such
tests are often used to detect or confirm viral infection and to identify asymptomatic spreaders
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[PCC+03, HZR+11, ZCV+09b, HLW+20]. In the HVC study, shedding in infected subjects was
first detected either on day 4 at 81 hours, designating early onset shedders, or on day 5 at 106 hours,
designating late onset shedders.
Four channels of physiological signals, including 3-axis accelerometry (ACC sampled at 32
sa/sec), heart rate (HR at 1 sa/sec), skin temperature (TEMP at 4 sa/sec) and electrodermal activity
(EDA at 4 sa/sec), were measured by the E4 devices. See Fig. 3.4a in Appendix 3.6.2 for
representative signals from an infected and a non-infected subject.
We implemented the three-stage data processing pipeline in Fig. 3.1b for sleep segmentation
and high dimensional feature extraction from the HVC data. The first stage (top branch in Fig. 3.1b)
consists of a pre-processing module, performing data conditioning, fine grain temporally-localized
feature extraction and abnormality filtering. The second stage (middle branch) implements the
HMM-FLDA module, performing adaptive sleep segmentation on non-abnormal data. The third
stage (bottom branch) is a post-processing module, aggregating the data into sleep and wake sessions
and performing coarse grain session-localized feature extraction.
Table 3.2 summarizes the parameter settings we used to implement the pipeline for the HVC
data. Figure 3.2 depicts how the pipeline constructs sleep/wake sessions and session-localized
features from the fine grained features.
Table 3.3: Features (196 in total) extracted from sleep and wake sessions for each day from subjects
in the HVC study.
Name Number Description
Duration 2 total sleep, night sleep
Onset/offset 2 night sleep only
HR summary 9×2 3 (mean, median, s.d.) × 3 (mean, median, sd within session) × 2 (sleep, wake)
HR linear coef. 6×2 3 (mean, median, sd) × 2 (coef.0, coef.1) × 2 (sleep, wake)
HR quadratic coef. 9×2 3 (mean, median, sd) × 3 (coef.0, coef.1, coef.2) × 2 (sleep, wake)
TEMP 24×2 same as HR
ACC 24×2 same as HR
EDA 24×2 same as HR
3.4.1.1 First stage: local features and abnormality filtering
Like other wearable sensors, the Empatica E4 captures data at high frequencies and, because
of the fact that they are worn by subjects in non-laboratory situations, the raw data collected
are often voluminous and noisy. To mitigate the impact of occasional poor readings and reduce
computational burden, the pre-processing stage performs data conditioning, local feature extraction
and abnormality filtering. First the missingness of a subject’s available data is evaluated, resulting in
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rejection of any subject with more than 40% missing time points. For each of the remaining subjects,
their data is segmented into non-overlapping time intervals, which we call epochs, of equal length
δt secs. The epoch length was set to δt = 10 mins to achieve a tradeoff between oversmoothing the
sleep/wake transitions (excessive length) and noise sensitivity (insufficient length). See Appendix
3.6.4 for additional discussion. Shorter epoch lengths may be more appropriate for classifying
other types of event states, e.g., for capturing quality of sleep or detecting transitions between
different sleep stages. For each of the 4 E4 signals, the module in Fig. 3.1b labeled "Local feature
extraction" computes statistical features over each epoch corresponding to the signal mean (MEAN),
signal median (MED) and signal standard deviation (SD). If a particular epoch has fewer than 90%
available samples, e.g., due to the E4 not being worn, the epoch is discarded.
These local features are then processed by the "Abnormality filtering" module to identify time
points at which outliers occur, labeled as non-normal data in Fig. 3.1b. Similarly to methods used
in network intrusion detection [BBK13], the module uses marginal k-means clustering and quantile
filtering to label time points as outliers (See Appendix 3.6.4.1). Subjects having less than 60%
normal data cannot be reliably segmented and are omitted from subsequent analysis.
The last pre-processing step consists of selecting a subset of the 12 local features to train
the HMM-FLDA sleep segmentation procedure. For this we select putative wake and sleep time
intervals in the early evening around 21:00 and in the twilight hours around 4:00. These time periods
were chosen since it is expected that most people would be awake at 9pm and sleeping at 4am.
The sleep/wake discrimination capability of each feature over these two intervals was measured
by a sleep/wake separability index (SWSI) computed over all non-abnormal subjects and over all
available days. The SWSI is defined similar to the geometric separability index (3.5):
SWSI(k) =
∑
t∈Twake∪Tsleep{ŷt + ỹt(k) + 1}MOD 2
|Twake|+ |Tsleep|
, (3.6)
where k = 1, . . . , p indexes the features, Twake and Tsleep are respectively the time intervals around
21:00 and 4:00 over all available days of data, ŷt is the putative label assigned to the k-th feature
xt(k), defined as ŷt = 1 if t ∈ Tsleep and ŷt = 0 otherwise, and ỹt(k) is the label of the nearest
neighbor of xt(k) among {xτ (k) : τ ∈ Twake ∪ Tsleep}. The criterion for including the k-th feature
among those that are used to train the HMM-FLDA is that SWSI(k) be greater than 0.7 for at least
75% of the subjects.
3.4.1.2 Second stage: adaptive sleep detection
Adaptive sleep segmentation was implemented using the HMM-FLDA procedure described in
Section 3.2. The initial training window (baseline) for training the HMM-FLDA (Algorithm 1) was
defined as the period from 0 to 36 hours, the time of viral inoculation. The test window length was
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chosen to be ∆t = 3 hours, which is based on our expectations about the time scale of immune
response induced changes in the E4 signal distributions subsequent to pathogen exposure. The most
rapid time scales of immune response are on the order of a few hours, e.g., inflammatory monocyte
recruitment [HHMH03]. Such a choice of ∆t will minimize the likelihood that the HMM-FLDA
algorithm loses track of covariate shifts from batch to batch. The range of training window lengths
d1, . . . , dL used by the optimization loop in Algorithm 1 was restricted to d1 = 12 to dL = 60 hours
to guarantee a good balance of wake and sleep samples over the window.
After the HMM-FLDA procedure labels the normal data, an "Abnormality classifier" module
identifies any abnormal samples (identified in Stage 1) that is physiologically meaningful and
reinserts it into the data stream, labeling it with the label of the sample immediately preceding it
(See Fig. 3.12 in Appendix 3.6.4.1). Finally, a modified median filter with a 90-min smoothing
window is applied to remove short bursty sleep periods of less than 60 mins. Such short sleep
periods are likely to lack deep sleep stages 3 and 4, which typically start 30 mins. after sleep onset
and can last 20 to 40 mins. [CD+05].
3.4.1.3 Third stage: session-level feature set
In the third stage of the pipeline, the sleep/wake sessions produced by the second stage are
aligned to particular calendar days. A full day session is composed of wake sessions and sleep
sessions. Any sleep session overlapping with a given day whose onset occurs before 5am (5:00) is
associated with the previous day session. The binary sleep/wake label is then appended to the local
features generated in the the first stage of the pipeline, doubling the total number of local features.
Then a set of session-level features are extracted by computing several statistical summaries over
daily wake and sleep sessions. This results in 196 session-level features that include the mean,
median, and standard deviation (sd) of the event labeled local features over a sleep or wake session.
All features related to standard deviation are log-transformed. The session-level features also
include the coefficients of linear and quadratic fits to the time course of these features over a sleep
or wake session. In addition session timing features, such as, sleep duration, sleep onset, and sleep
offset are included in the session-level feature set. See Table 3.3.
3.4.2 Online sleep segmentation
We emulate an online implementation of the pipeline in Fig. 3.1b by reapplying it successively
to all available data at the end of each day. Daily updating of the segmentation corresponds to the
real-world scenario where data is uploaded from the E4 device once per day, corresponding to the
data acquisition rate in the HVC study. Continuous (real-time) updating will only become practical
when devices have sufficient power for continuous data transfer or onboard processing. Below we
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Table 3.4: Top 4 E4 wake/sleep features for predicting clinical outcome within 24 hours (later than
day 3) of inoculation day (day 2) based on device data collected over the range 0-60 hours (day 1
and 2).
logistic regression model continuation-ratio regression model
Feature Coef. AUC Feature Coef.
AUC
Early Late No onset
HR MED.sd (sleep) -3.921 0.758 HR MED.sd (sleep) -5.073 0.882 0.718 0.864
ACC SD.linear.coef1 (wake) -14.468 0.737 HR MEAN.sd (sleep) -4.466 0.706 0.628 0.773
HR MED.quad.coef2 (sleep) 4.318 0.707 Total duration -0.599 0.676 0.551 0.750
Offset -1.452 0.697 Night duration -0.616 0.647 0.500 0.705
illustrate the online implementation for a case of pre-infection segmentation before shedding occurs,
and a full time course segmentation at the end of the study. For additional details see Appendix
3.6.5.
3.4.2.1 Illustration: pre-infection segmentation
Here only the first 60 hours (up to day 3 at 12pm) of the data are available to the pipeline. The
first 60 hours include the inoculation time (36 hours) and the first two nights of sleep. Note that no
infection (shedding) is detected before day 4 at 81 hours. The preprocessing stage of the pipeline
removed 5 subjects with excessive missing or abnormal data: 2 of these subjects had more than
40% of their time points missing and 3 subjects had more than 40% abnormal time points. For
the remaining 20 subjects local feature selection was accomplished by applying SWSI (3.6) to all
12 variables to contrast early evening periods (19:00-22:00) to twilight periods (2:00-5:00). Only
three features were found to have SWSI above 0.7 for at least 75% of the subjects: the mean and
median heart rate (HR MEAN and HR MEDIAN) and the standard deviation of the magnitude
accelerometer (ACC SD). As the mean and median heart rate are highly correlated and the SWSI
of HR MEAN has lower 25% quantile than does the HR MEDIAN, only the HR MEDIAN and
ACC SD were selected. Three hour long sleep and wake periods were necessary in order to obtain a
sufficient number of representative time samples since only two days and nights are available.
3.4.2.2 Illustration: full time course segmentation
The full time course (0-270 hours) of a subject’s data was made available to the pipeline. No
subjects had more than 40% missing time points over this period. Stage 1 abnormality filtering
resulted in elimination of 5 subjects as excessively abnormal, who were removed. To compute
SWSI for variable selection on each of the remaining 20 subjects, we used shorter putative wake
periods (21:00-22:00) and sleep periods (4:00-5:00) since there are many more available days and
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nights than in the 60 hour pre-infection time period. Applying the same SWSI variable selection
criterion three features were selected to train the HMM-FLDA: HR MED, HR SD, and ACC SD.
3.4.2.3 Clinical outcome prediction
We used the feature set generated by the pre-infection segmentation to perform early detection
of infection. Two clinical outcomes were considered: 1) a binary infection state (whether or not the
subject will shed virus anytime after 60 hours) designating the subject as infected or non-infected;
and 2) the ternary infection state corresponding to onset time of viral shedding. The three onset
times are defined as: early onset shedding (first detected by PCR at 81 hours), late onset shedding
(first detected by PCR at 106 hours), and no onset shedding (subject never sheds virus). Among the
20 subjects whose 0-60 hour data passed the abnormality filtering test, 9 of them were infected and
11 were non-infected. Among those infected, 3 were early shedders and 6 were late shedders.
Two predictor models were used for each of these outcomes, which were trained only on the
sleep/wake features collected on inoculation day (wake/sleep sessions for day 2). For prediction of
whether a subject will shed or not we applied logistic regression (LR) [FHT01] and for prediction
of onset time we used continuation ratio (CR) regression [Agr10], which can be interpreted as a
discrete version of the Cox regression model [HvdAS01].
For both the logistic and the continuation-ratio models the classification capability of individual
features is evaluated by leave-one-out cross-validation. The top 4 discriminative features are
reported in Table 3.4, together with their corresponding regression coefficients and a detection
performance criterion: the area under the ROC curve (AUC). AUC is a measure of the accuracy of a
binary classifier and a value of AUC near 1 means very high accuracy. For CR regression, since
there exist three classes, three different AUCs are calculated using the “one-versus-the-rest” strategy
[Bis06]. The CR performance is rank ordered in decreasing order of the minimum of the AUC’s for
Early, Late and No onset. See Appendix 3.6.5 for boxplots of these top 4 features.
The top feature for both LR and CR models is a sleep feature: the standard deviation of the
median heart rate (HR MED.sd (sleep)). Interestingly, most of the 4 top ranked features come from
sleep sessions, with the exception of the linear coefficient to a linear fit to the time course of the
standard deviation of ACC, denoted ACC SD.linear.coef1 (wake). Features related to sleep heart
rate variation (HR MED.sd, HR MEAN.sd) and sleep duration (total duration, offset, night duration)
are most discriminative.
The results of running full timecourse sleep/wake segmentation reveals striking temporal
differences between shedders and non-shedder features. Figure 3.3 indicates qualitatively different
total sleep duration and sleep offset behaviors in these two groups over the full 11 day duration of
the study. The non-shedder group sleeps on the average 2.041 hours longer than does the shedder
group (p-value < 0.005 using two-sided t-test) over this time period. This is consistent with studies
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Figure 3.3: Offset (wake-up time) and total sleep duration (night and day sleeping) features extracted
by the proposed HMM-FLDA pipeline applied to the experimental human viral challenge study
(HVC) when all time points (0-270 hours) are available. Viral inoculation took place on day 2 and
all infected people (shedders) started shedding virus on day 4 or day 5.
of the effects of sleep on the course of respiratory infection [DRR+00]. The mean sleep duration
deficit among the shedders gradually decreases over time, and the trend reverses after day 6. The
offset feature illustrates that non-shedders tend to wake-up later than the shedders until day 9 of the
study.
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3.5 Discussion and Conclusions
We have developed an unsupervised adaptive algorithm for classification of latent event states
from multivariate physiological data collected from a wearable device. The algorithm adapts
to perturbations of the initial training distributions using a sequential transfer learning model to
mitigate covariate shift. The proposed algorithm operates without requiring a priori information
about true sleep/wake states and is capable of automatically detecting anomalies and abnormal data
records. Numerical simulations established significant advantages of our model relative to hidden
Markov approaches to hidden event classification.
The results presented in this paper are not without limitations. The HVC experiment has
the limitation of small sample size and the classes are imbalanced. The negative effect of class
imbalance can be compensated, to an extent, using methods such as the synthetic minority over-
sampling technique (SMOTE) [CBHK02]. While no substitute for increasing actual sample size, we
have demonstrated that SMOTE can improve clinical outcome prediction accuracy as measured by
AUC (Table 3.11 in Appendix E). Another limitation is that the HVC experiment lacks ground truth
information about the true sleep/wake states of the subjects. The simulation study we presented
emulating a similar HVC experiment with ground truth is an in-silico validation but a controlled
experiment, e.g., performed in a sleep lab, would provide better confirmation. It would also be
worthwhile to test the algorithm in a larger scale experiment that collects self-reported sleep diaries
in addition to clinical data.
There are also limitations of the proposed HMM-FLDA adaptive event segmentation algorithm.
First, the algorithm may fail if there is an abrupt and excessively large shift in the event class
distributions from time to time. More generally, loss of track due to abrupt changes is a limitation of
the gradual self-training approach [KML20],[CWB11] commonly adopted in transfer learning. In
extreme cases this limitation may be insurmountable as there are fundamental theoretical limits that
limit tracking ability of any adaptive algorithm [HL94]. If the abrupt shift in distributions persists
over time, a possible remedy would be to episodically re-initialize the HMM-FLDA algorithm
during the adaptation phase. Secondly, the classification accuracy of FLDA may be poor if the event
classes are not linearly separable. At the possible cost of reduced simplicity of implementation, use
of a non-linear classifier in place of FLDA would overcome this limitation, e.g., using kernelized
FLDA or a Support Vector Machine (SVM) [FHT01].
We conclude by pointing out that the proposed framework for adaptive multi-channel event
segmentation and feature extraction easily generalizes beyond the setting of the binary sleep/wake
segmentation illustrated in this paper. Monitoring different stages of sleep or different wake activity
types would be a natural non-binary extension. With the continuing advances in the capabilities of
wearable devices for digital health, many new applications will be enabled by continuous multi-event
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tracking. These could include accurate behavioral and health assessment tools that will advance
personalized health care.




3.6.1 Human Viral Challenge (HVC) Study
A human viral challenge (HVC) study was conducted in 2018 as a collaborative effort between
Duke University and University College London under a grant from the Defense Advanced Research
Projects Agency (DARPA) under the PROMETHEUS program. Thirty nine healthy volunteers
between the ages of 18 and 55 were enrolled as participants in the study, which took place in the
United Kingdom.
The HVC was divided into outpatient and confinement phases. During the confinement phase
participants stayed overnight for a period of 8-11 days in total from the morning before the day the
viral challenge was administered to the end of confinement. During the outpatient phase subjects
were evaluated for health conditions by tests including ear, nose and throat (ENT), respiratory and
cardiac assessment. In addition to other data types not relevant to this paper, wearable device data
(Empatica E4) and clinical infection status data (viral shedding) were collected from the participants.
All data was anonymized prior to transfer to Duke and Michigan for the analysis described in this
paper.
Participant exclusion criteria: Chronic respiratory disease (asthma, COPD, rhinitis, sinusitis) in
adulthood. Inhaled bronchodilator or steroid use within the last 12 months. Use of any medication
or other product (prescription or over-the-counter) for symptoms of rhinitis or nasal congestion
within the last 3 months. Acute upper respiratory infection (URI or sinusitis) in the past 6 weeks.
Smoking in the past 6 months or >5 pack-year lifetime history. Subjects with allergic symptoms
present at baseline. Clinically relevant abnormality on chest X-ray. Any ECG abnormality. Those
in close domestic contact (i.e. sharing a household with, caring for, or daily face to face contact)
with children under 3 years, the elderly (>65 years), immunosuppressed persons, or those with
chronic respiratory disease. Subjects with known or suspected immune deficiency. Receipt of
systemic glucocorticoids (in a dose ≥ 5 mg prednisone daily or equivalent) within one month, or
any other cytotoxic or immunosuppressive drug within 6 months prior to challenge. Known IgA
deficiency, immotile cilia syndrome, or Kartagener’s syndrome. History of frequent nose bleeds.
Any significant medical condition or prescribed drug deemed by the study doctor to make the
participant unsuitable for the study. Pregnant or breastfeeding women. Positive urine drug screen.
Detectable baseline antibody titres against influenza challenge strains. History of hypersensitivity
to eggs, egg proteins, gentamicin, gelatin or arginine, or with life-threatening reactions to previous
influenza vaccinations.
Confinement phase study: The eight days of the confinement phase consisted of a 36 hour healthy
reference time period (baseline), inoculation at 36 hours (exposure), and a post-baseline time period.
The E4 data of the participants was collected over the entire period and viral shedding was measured
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once per day in the morning. On the second day (day 2) at approximately noon (36 hours from start
of study) each participant was challenged by a GMP influenza A/California/04/2009-like (H1N1)
virus strain. The inoculation was administered by inserting intra-nasal drops on a single occasion
with diluted inoculum with an average dose of 106 TCID50 in 1mL PBS divided equally between
the two nostrils. This resulted in an average attack rate of 44%. Following inoculation, advice
regarding hand hygiene was given and subjects were provided with alcohol hand gel and face-masks
if they moved between the inoculation room and the quarantine ward.
Viral shedding assay: Over the confinment phase of the study, viral shedding was measured once
per day through a nasal lavage. The collected fluid was aliquoted into sterile microfuge tubes
and centrifuged for analysis of cells, and lavage fluid was later analysed by singleplex PCR to
quantify the degree of viral shedding of the inoculated strain. Multiplex PCR was performed on
the pre-inoculation lavage and post-inoculation lavage collected during the study to exclude the
presence of other respiratory viruses.
Wearable device and protocol: Over the confinement phase of the study, subjects agreed to comply
with the following wearable device protocol: 1) they wear the Empatica E4 device properly, i.e.,
comfortably tight on the wrist of their dominant hand; 2) they take care to maintain the device and
protect it from shocks, water immersion, and other damage; 3) they wear the Empatica continuously
without interruption except for periods that they were showering, recharging, or uploading data. The
E4 has several sensors that measure physiological parameters including blood volume pulse, skin
conductance, temperature, and movement. The E4 was recharged once per day during which time
each participant’s data were uploaded to a cloud server for processing using Empatica proprietary
software.
The result of this processing was reported at sub-second temporal resolution as the following
variables: heart rate (1sa/sec), skin temperature (4sa/sec), electrodermal activity (4sa/sec), and
3 axis accelerometer (32sa/sec). These were mapped to a vector of four variables at each time
point: HR, TEMP, EDA and ACC, respectively, where ACC was computed as the Euclidean norm
(magnitude) of the 3 dimensional acceleration vector. Subjects were trained on best practices for
wearing and maintaining the E4 devices over the course of the confinement phase of the study.
Of the 39 participants enrolled in the HVC, only 25 had sufficient quality E4 data to be included
in the analysis presented in Section 3.4. A histogram of the demographic data of these 25 participants
is shown in the figure below. The other participants had wearable data that suffered from factors
such as device failure, excessive missingness or data corruption, making their data unusable for
our analysis. Non-compliance with wearable device protocols, data upload errors, and device









































































Demographics of 25 participants in HVC study.
3.6.2 HVC data
The raw time course E4 data of two representative subjects in the HVC study are shown in
Fig. 3.4. Subject 1 (Fig. 3.4a) did not become infected after inoculation on the second day of the
study (day 2), i.e., this subject had no detectable level of viral shedding at any time over the 8-11
days of the study, while Subject 2 (Fig. 3.4b) became infected. The four E4 signals shown in the
figure are heart rate (HR), accelerometer (ACC), temperature (TEMP), and electrodermal activity
(EDA). The data clearly shows diurnal differences in signal behavior, corresponding to the cycling
of sleep and wake states of these subjects. A quadratic trend in heart rate and temperature is clearly
visible in Subject 2, the trend peaking at around 144 hours. Robustness to this trend is desirable and
motivated the proposed HMM-FLDA sequential adaptive sleep/wake segmentation algorithm.
3.6.3 Simulation study
In this section we include additional figures supporting the simulation study reported in Table 3.1
and described in Section 3.3 of the main text. We also report on in-sample performance comparisons
between the proposed HMM-FLDA and the competing HMM and dHMM algorithms.
As mentioned in Sec. III these simulations were intended to emulate the experimental HVC
data used in Sec IV. In Fig. 3.5 we show realizations of two simulated device channels, X1 and
X2, emulating the HR MED and ACC SD features in the HVC study, under the unstable++, and




Figure 3.4: Four channel device data (Empatica E4) from human viral challenge (HVC) study for
two subjects (Subjects 1 and 2). The four channels are: HR (red), ACC (green), TEMP (blue)
and EDA (purple). Time 0hrs corresponds to 12am local time on the first day (day 1) of the study.
Viral inoculations were administered to all subjects on the morning of the second day (day 2), i.e.,
between 32hrs and 36hrs. (a) data from a Subject 1 who had no detected shedding (Non-infected
class); (b) data from Subject 2 for whom shedding was detected (Infected class).
to real E4 data.
Table 3.5 provides a more comprehensive report of the results of our simulations of the proposed
HMM-FLDA event segmentation than does Table 3.1 in the main text. Three segmentation algo-
rithms are compared: the proposed HMM-FLDA, the HMM and a detrended HMM (dHMM) using
LOESS pre-filter to detrend prior to applying HMM. The simulation parameters for the random
wake/sleep event transitions, event conditioned data distributions, and the covariate shift are the
same as were used for Table 3.1.
The top part of the table shows in-sample performance and the bottom part shows out-of-sample
performance showing both mean and standard deviation (SD) of the performance measured over
60
100 simulation trials. Only the means of the OoS part of this table were shown in Table 3.1. The
performance of the best performing method in terms of the MEAN performance is bolded.
For the in-sample results (top part of table), event segmentation performance on the training
set is shown. For the out-of-sample results (bottom part of table), an hold-out dataset was created
from an independent simulation using the same model as the training set. The performance of each
segmentation algorithm, trained only on the training set, was evaluated on the hold-out set. Note
that the proposed HMM-FLDA would never be implemented in this way as such an implementation
would turn off the adaptation mechanism on future data. The bottom part (OoS) of Table 3.5
provides evidence for the accuracy and robustness of the proposed approach.
The bolded entries in Table 3.5 denote the best mean performance per model (stable, unstable++,
unstable+-) and performance criterion (Accuracy, F1, Cosine dist, Onset diff, and Duration diff).
The asterisk on an MEAN entry in the OoS part of Table 3.5 indicates the best performing method
for each of the five criteria where best was determined using a one-sided paired t-test of significance
applied to the set of 1000 simulations thresholded at a 0.01 level of significance. The OoS part
of Table 3.5 has an additional row, P-VALUE, that is the p-value of the one-sided paired t-test
that the proposed HMM-FLDA has better performance than both the HMM and dHMM. Only
two P-VALUE entries are not significant, the case unstable++ for cosine distance and the case
unstable+- for onset diff. For the former case, dHMM is better than HMM but dHMM cannot be
characterized as better than the proposed HMM-FLDA (0.01 level of significance). For the latter,
HMM is better than the proposed for onset diff estimation. Hence, except for the onset diff criterion
in the unstable+- case, the proposed method is equivalent or better than the other methods at a 0.01
level of significance.
In Fig. 3.6 is shown boxplots and density plots of the out-of-sample (OoS) simulation of all
three scenarios, whose mean is shown in Table 3.1. These plots show the distribution of errors
committed by the various methods compared in terms of event labeling accuracy, onset estimation
error, and duration estimation error when the trained methods are applied to independent sample
trajectories drawn from the same distribution. As compared to the others the proposed method has a





Figure 3.5: Realizations of simulated signals for: (a) Unstable++ case for which the sleep and wake
session both have concave trends after 36 hours in channel X1; (b) Unstable+- case where the
sleep and wake sessions have convex and concave trends, respectively, in channel X1; (c) another
realization of Unstable+- case with sleep and wake sessions whose trends hit their apogee at a
different time.
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Table 3.5: Performance of the proposed adaptive transfer learning algorithm as compared with
standard HMM operating on the original data (HMM) and operating on LOESS detrended data
(dHMM).
Setting Methods Accuracy F1 Cosine dis. Onset diff. Duration diff.
(0, 0, 0, 0) HMM MEAN 0.9982 0.9987 0.9968 0.0236 0.0427
stable SD 0.0012 0.0009 0.0021 0.0199 0.0287
dHMM MEAN 0.9981 0.9986 0.9966 0.0271 0.0450
SD 0.0012 0.0009 0.0022 0.0209 0.0288
Proposed MEAN 0.9981 0.9987 0.9967 0.0259 0.0420
SD 0.0012 0.0009 0.0021 0.0218 0.0278
(15, 10, 0.5, -0.5) HMM MEAN 0.8744 0.9052 0.8234 2.4786 3.6780
unstable++ SD 0.0642 0.0520 0.0754 1.5541 2.2121
dHMM MEAN 0.9558 0.9680 0.9306 0.9912 1.1574
SD 0.0502 0.0375 0.0713 1.6795 1.4117
Proposed MEAN 0.9487 0.9636 0.9146 0.9813 1.4605
SD 0.0498 0.0363 0.0781 0.9889 1.3812
(-15, 15, 0.5, -0.5) HMM MEAN 0.9371 0.9513 0.9185 0.4329 2.0992
unstable+- SD 0.0836 0.0660 0.1043 0.7836 2.7722
dHMM MEAN 0.9483 0.9615 0.9253 0.4909 1.4544
SD 0.0666 0.0505 0.0928 0.9295 1.8854
Proposed MEAN 0.9923 0.9946 0.9868 0.1631 0.1699
SD 0.0221 0.0157 0.0365 0.4648 0.4651
stable HMM (OoS) MEAN 0.9981 0.9987 0.9968 0.0165 0.0307
SD 0.0005 0.0004 0.0009 0.0051 0.0079
dHMM (OoS) MEAN 0.9981 0.9986 0.9967 0.0253 0.0373
SD 0.0015 0.0011 0.0027 0.0163 0.0211
Proposed (OoS) MEAN 0.9980 0.9986 0.9964 0.0168 0.0313
SD 0.0015 0.0011 0.0027 0.0163 0.0211
P-VALUE 1.0000 1.0000 1.0000 0.7850 0.8735
unstable++ HMM (OoS) MEAN 0.8959 0.9209 0.8559 1.6704 2.9169
SD 0.0679 0.0547 0.0792 1.0972 2.2120
dHMM (OoS) MEAN 0.9127 0.9231 0.8957* 2.4709 2.2653
SD 0.1284 0.1377 0.1089 2.6125 3.1967
Proposed (OoS) MEAN 0.9356* 0.9544* 0.8904* 1.0679* 1.5756*
SD 0.0353 0.0263 0.0533 0.7614 1.0664
P-VALUE 9.94E-07 1.07E-10 0.9521 4.04E-28 3.73E-08
unstable+- HMM (OoS) MEAN 0.9369 0.9510 0.9187 0.2763* 1.9750
SD 0.0810 0.0635 0.1019 0.4079 2.5778
dHMM (OoS) MEAN 0.9271 0.9370 0.9114 1.0170 2.0131
SD 0.1151 0.1298 0.1112 2.1413 3.2464
Proposed (OoS) MEAN 0.9758* 0.9833* 0.9564* 0.3712 0.3817*
SD 0.0326 0.0226 0.0591 0.6225 0.5472




Figure 3.6: (a) Boxplots for label accuracy, onset estimation error, duration estimation error for
simulations shown in Table 3.1 for out-of-sample (OoS) simulation performance (excluding two
outliers by dHMM method in the stable case). (b) corresponding interpolated densities associated
with (a) (for unstable+- case, the density plots are shown for a zoomed in region to better compare
density concentration). 64
Table 3.6 shows runtime comparisons. The proposed method runs slower than HMM and
dHMM. However, 1 minute run time of HMM-FLDA is still small as compared to the 8-11 days
time period of HVC data. Furthermore, the method is not optimized in terms of runtime and can
likely be accelerated.
Table 3.6: Average run time (seconds) per replication of the proposed adaptive transfer learning
algorithm as compared with standard HMM operating on the original data (HMM) and operating
on LOESS detrended data (dHMM) on a 2.3 GHz Dual-Core Intel Core i5 processor with 16 GB
RAM.
stable unstable++ unstable+-
HMM 0.4347 0.5612 0.4913
dHMM 0.7396 0.8351 0.8347
Proposed 53.5126 54.3654 55.2601
3.6.4 Analysis pipeline implementation for HVC study
Here we provide additional details on our implementation of the pipeline of Fig. 3.1b, in the
context of the Human Viral Challenge Study Empatica E4 data. We illustrate the implementation for
both the pre-infection time-line (0-60 hours) and the full time-line (0-270 hours). First we describe
the features used for abnormality detection.
Wearable devices are subject to outliers, anomalies and other abnormal sensor readings. Some
types of outliers are physiological and are important to include in the final event-segmented data
stream. Other types of outliers are technical and can be due to device malfunction or improper
wearing of the device. These technical outliers must be removed early in the analysis pipeline so
as to not compromise downstream event detection and labeling performance. We use a two stage
procedure for isolating such anomalies in the pre-processing stage (Stage 1) of the pipeline in Fig.
3.1b and classifying them as physiological vs technical outliers for possible re-insertion in the
transfer learning stage (Stage 2). The first stage of the procedure is called abnormality filtering
and the second stage is called abnormality classification, which will be discussed below. Both
procedures apply standard outlier detection methods to a set of predefined features. However, since
the purposes of these procedures are different, the outlier detection thresholds are different.
Features for abnormality filtering (Stage 1) and classification (Stage 2): The best features to
use for detection of abnormal samples will be experiment dependent and device dependent. Here
we explain how the abnormality filtering features were selected for the HVC experiment where
participants wore the Empatica E4 device, as discussed in Section 3.4. Based on experiments on an
Empatica E4 performed in our laboratory we determined that there are three principal causes for
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abnormal measurements, each manifesting abnormality in different combinations of channels. See
Fig. 3.7. For abnormality filtering and classification physical intuition motivated us to select three
temporally localized features, HR MED, TEMP MED and ACC SD, as they are especially affected
by the types of abnormalities described below.
• Device not worn (NW). Effect: Skin temperature sensor (TEMP) reads ambient temperature
and activity sensor (ACC) records little or no physical movement. Primary features affected:
median of TEMP and standard deviation of ACC magnitudes are abnormal.
• Device loss of contact (LOC). Effect: Intermittent skin contact causes spurious signal dropout.
Primary features affected: median of TEMP and HR and standard deviation of ACC magni-
tudes are abnormal.
• Subject engages in intense activity (Active). Effect: heart rate (HR) and activity sensor (ACC)
readings increase significantly over burst of physical activity. Features primarily affected:
median of HR and standard deviation of ACC magnitudes are abnormal.
In the HVC study we used HR MED and TEMP MED features for abnormality filtering while
we used HR MED, TEMP MED and ACC MED for abnormality classification. The combination
of HR MED and ACC MED is especially important for classifying abnormalities that are due
to physiological causes,e.g., when a subject is engaged in intense exercise which is legitimate
wake session activity that should be reinserted in the final segmented data stream in Stage 2 of the
pipeline.
Figure 3.8 illustrates three simulated cases with different levels of separability. Two variables
(X1, X2) are generated from BVN(µ1, µ2, 1, 1, 0). For samples in Class 0 (indicated by red dots),
µ1 = µ2 = 0, while for samples in Class 1 (indicated by green triangles), we considered three
settings: (1) µ1 = µ2 = 0; (2) µ1 = µ2 = 1.5; (3) µ1 = µ2 = 3, corresponding to non-, weakly and
strongly separable scenarios. SI values based on both projection distance and Euclidean distance
are reported for each case. We observe that SI is indeed able to effectively characterize separability,
and that the projection distance is preferred since it gives value closer to 0.5 in the non-separable
case and value closer to 1 in the strongly separable case.
3.6.4.1 Online feature extraction pipeline: applied to 0-60 hours of data
Here we describe details of the proposed pipeline, illustrating with the pre-infection (0-60 hours)
data. The result of applying the pipeline to the full data (0-270 hours) is described afterward.
Stage 1: pre-processing Pre-processing in stage 1 of the pipeline accomplishes three tasks:
temporal windowing and conditioning; local feature extraction, and abnormality filtering. Here we
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Time
Figure 3.7: Experimental Empatica E4 data collected from one of the co-authors of this paper under
three different conditions: active, not worn and loss of contact. Shown are measured values of the
variables used in our selected abnormality feature set: HR median, TEMP median and ACC sd.
Note the very different values of these three parameters between the active, not worn and loss of
contact classes.
illustrate each of these tasks when the pipeline is applied to the pre-infection data, i.e., only the first
60 hours (2 days and two nights) are available. Results of applying the pipeline to the full data from
0 to 270 hours are presented for comparison in Section 3.6.4.2.
Stage 1: temporal windowing and conditioning
The tuning parameters and their settings for Stage 1 of the pipeline are
• Temporal window (epoch) length: 10 mins
• Subject availability threshold: 60%
• Subject abnormality threshold: 40%
The subject availability threshold of 60% is applied to filter out subjects that have E4 data
missingness of greater than 40%. Subject availability is quantified the proportion of time points
not missing among the full set of sampling times (number of seconds) over the 0-60 hour period.
Subjects with less than 60% data availability are not further processed. Figure 3.9 shows that 2
subjects in the HVC cohort (Subjects with identified 13 and 17) have insufficient data availability
over this time period.
Stage 1: abnormality filtering
The abnormality filtering module operates as follows. After temporally localized summary
statistic features are extracted from the device for each subject, these features are tested for
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(a) SI1 = 0.470, SI2 = 0.605 (b) SI1 = 0.750, SI2 = 0.785 (c) SI1 = 1.000, SI2 = 0.990
Figure 3.8: Separability indices under three simulated scenarios: (a) non-separable, (b) weakly
separable, (c) strongly separable, where SI1 is based on projection distance and SI2 is based on
Euclidean distance.
Figure 3.9: Subject availability for the sleep/wake segmentation when the first 60 hours of data
is available for subjects in the HVC study. Two subjects (13 and 17) have excessive (> 40%)
missingness. The observed proportion is defined as the ratio of the number of time samples in the
subject’s data record and the total number of sampling times that should be available over the 60
hour period.
abnormality using a clustering-based anomaly detection procedure. The procedure labels the
abnormal samples as non-normal data and these are temporarily removed from the data stream.
The clustering-based anomaly detection procedure is as follows. Define the vector-valued local
features for the i-th subject at the t-th time instant X̃i,t = (X̃1i,t, . . . , X̃Mi,t), where here the feature
dimension is M = 12. As explained above, only two of these features was used for abnormality
filtering: HR MED and TEMP MED. For each subject i, a combination of k-means clustering
and quantile thresholding is used to determined a normal region Ci in this two dimensional feature
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Figure 3.10: Abnormal proportion for the sleep/wake segmentation over 0-60 hours for subjects in
the HVC study. Three subjects have an excessive number of abnormal time samples (greater than
40%).
space. Subject i’s feature instance at time t is declared non-normal if it is not in Ci. While we
also investigated abnormality using k-means clustering in the full 2 dimensional feature space of
HR MED and TEMP MED (See Fig. 3.15b), the abnormality filtering method we adopted in the
pipeline of Fig. 3.1b performs k-means clustering separately on each each of the feature dimensions.
For the HVC data, where the events of interest are sleep and wake, the k-means algorithm is
set to extract 3 clusters corresponding to sleep and wake (normal) and non-normal classes. Let
{Sim1, Sim2, Sim3} be the resulting clusters with centers (centroids) {µim1, µim2, µim3}. When the
normal and non-normal cluster classes are well separated it is easy to construct a normal region Ci,
e.g., all points in the feature space having a majority of k-nearest neighbors in { ˜(X)i,t}t outside of
the non-normal cluster. More often, however, the separation between the normal and non-normal
cless is not sufficient and a different method is needed. We determine Ci as the set complement of the
hyper-rectangle of minimal volume whose empirical coverage probability is 95%. The rectangular
edge lengths and position are thus determined by the marginal sample quantiles along each feature
dimension.
Specifically, we define a sequence of subject-dependent cutoff values {ci1, . . . , ciM} for abnor-
mality. The rectangular normal region is designated as the Cartesian product Snori = S
nor
i1 × . . .×
SnoriM , where
Snorim =
Sim1 ∪ Sim2 if |µim2 − µim1| < |µim3 − µim2|,Sim1 o.w..
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Cutoff values defining the normal set are defined as
cim =
Q0.025({X̃mi,t ∈ Snorim }) if µi,nor > µi,abn,Q0.975({X̃mi,t ∈ Snorim }) o.w.,
where Qq(·) is the q−th quantile of the samples, and µi,nor, µi,abn are the centroids of the normal
and non-normal set, respectively. For the experimental HVC data we used the 95% outlier rule to
define the lower and upper quantiles as 2.5% and 97.5%, but less stringent threshold values may be
adequate for other datasets.
For the subjects in HVC study with the first 60 hours of data available, Figure 3.10 shows a
bar-plot of the resulting non-normal data proportion for each subject. Three subjects (7, 15 and 21)
had excessive abnormal data and were eliminated from further processing.
Thus, when taken with subjects who had excessive missingness, a total of five subjects were
excluded from further analyses.Some of these subjects may come back into the analysis when a
greater amount of data is available (see subsection C for the case where 0-270 hours are available).
Feature selection for training adaptive segmentation algorithm: As explained in the main text,
we extracted a subset of the 12 local features using the sleep/wake separability index (SWSI) (3.6).
The SWSI is computed over all subjects, to contrast each feature over the putative sleep periods
2:00-5:00 and the wake periods 19:00-22:00 in the 0-60 hour time interval of the pre-infection data
window. Figure 3.11 shows the resulting SWSI for each of the 12 features, in descending order of
median. Applying the selection rule that a selected feature must be greater than 0.7 for at least 75%
of the subjects, three features are above threshold: HR MEAN, HR MED and HR SD and, as HR
MEAN and HR MED are highly correlated, we chose eliminated HR MEAN since it has a lower
75% quantile than does HR MED.
Stage 2: adaptive segmentation The HMM-FLDA procedure is implemented for a given subject
on all the time points that pass through the abnormality filter. The details of the HMM-FLDA are
given in Sec 3.4.1.2.
Stage 2: Separability index
By definition (3.5), SI is the proportion of samples that share the same label with their nearest
neighbors, and hence SI ∈ [0, 1]. Intuitively, when samples from two classes form two tight,
well-separated clusters with little overlap, the nearest neighbor of one sample from, say, Class 0,
will most likely belong to Class 0 as well, which will result in a large SI value close to 1. In contrast,
when samples from two classes follow exactly the same distribution, i.e., completely non-separable,
then the nearest neighbor of one sample will have equal probability of being Class 0 or Class 1, and
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Figure 3.11: Box-plot of sleep/wake separability index (3.6) for pre-infection (0-60 hour) data,
showing the spread of the 12 local features extracted from wearable data in the first stage of the
processing pipeline. Excluding HR MEAN, which is highly correlated with HR MED and has a
smaller 25% quantile, two local features (HR MED, ACC SD) are selected.
thus, the SI of these samples is close to 0.5. A large SI value implies strong separability of classes,
and is usually an indication of reliable prediction. SI also depends on the measure of distance used
to determine the nearest neighbors. The projection distance captures the difference among samples
on the optimal direction w that is most relevant to distinguishing between the two classes, and
thus is better than Euclidean distance in regard to characterizing separability, as demonstrated by
Figure 3.8.
Once the HMM-FLDA event classification procedure terminates the initial sleep/wake segmen-
tation will have missing time points that have been removed by the abnormality filter. Some of
these abnormal time points, e.g., those due to rare physiological events like an exercise session, are
reinserted into the data stream. The method to do this is based on an abnormality classification
procedure discussed in the next subsection.
Stage 2: Abnormality classification and reinsertion
The purpose of the abnormality classification module is to identify, re-insert and assign an event
label to physiologically meaningful non-normal data, i.e., abnormalities that are not due to technical
issues associated with device failure or improper wearing of the device. Any such non-normal
samples re-inserted into the data stream inherit the event class label of the session into which the
sample’s time stamp falls.
Using predefined features HR MED, TEMP MED, and ACC SD, abnormality classification
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was performed using a decision tree using marginal quantile thresholding. For each non-normal
sample, we applied a standard 1.5 interquartile range (IQR) test [Tuk77, HIT86] to each feature
independently. If a feature falls outside of this range it is declared an outlier and further classified.
The lower and upper endpoints of the 1.5 IQR interval are defined as:
LOWER = Q0.25 − 1.5 ∗ (Q0.75 −Q0.25),
UPPER = Q0.75 + 1.5 ∗ (Q0.75 −Q0.25). (3.7)
Here Q0.25 and Q0.75 are the 25% and 75% sample quantiles of the feature empirical distributions
computed over the detected sessions. All samples that were categorized as "Wake" or "Active" were
incorporated back into the corresponding session. Abnormal samples assigned to other categories
were discarded. The decision tree for this procedure is shown in Figure 3.12.
Excluded
observations
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Figure 3.12: Decision tree for abnormality classification module for the HVC data. Non-normal
samples (excluded observations) identified by the abnormality filter in first stage of the pipeline of
Fig. 3.1b are excluded from the training set used by the second stage transfer learning algorithm.
The abnormality classifier re-evaluates these samples for possible re-insertion and labeling of
physiologically meaningful abnormalities. The classifier classifies the samples into final categories
of: device not worn (NW), loss of contact (LOC), Wake, Active and Other. Samples that are
classified as "Active" or "Wake" are re-inserted into the corresponding session.
Stage 2: Median filtering
After processing by HMM-FLDA and reinsertion of physiologically meaningful abnormalities,
there commonly exists short bursts of sleep sessions. We expect that some of these are actually
sleep while others correspond to resting without sleep. While such bursty behavior could possibly
be directly incorporated into an HMM model, e.g., using a semi-Markov switching process [Ani08],
we took a simpler approach that applies a modified median filter with 90 min smoothing window
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(median filter of order 9) that has the effect of merging sleep sessions shorter than 60 mins into a
wake session. We choose to eliminate such short sessions in order to eliminate disambiguate resting
and light naps from sleep sessions, defined as a session having deep sleep stages, i.e., Stage 3 &
4 of non-rapid eye movement (NREM), usually starting 30 minutes after sleep onset and lasting
approximately 20 to 40 minutes in the first sleep cycle [CD+05]. Hence, the 60-minute threshold is
designed to eliminate putative sleep sessions that had no deep sleep stages.
3.6.4.2 Offline feature extraction pipeline: applied to 0-270 hours of data
Stage 1: pre-processing When evaluated over the time period 0-270 hours, no subjects had
missingness greater than 40% and thus none were filtered out due to inadequate data availability.
However, five subjects were found to have greater than 40% abnormal samples and were filtered
out. Figure 3.13 shows the bar-plot of the abnormal proportions for all 25 subjects, showing the 5
subjects exceeding the 40% threshold for inclusion.
Figure 3.13: The bar-plot of abnormal data proportions over all time points (0-270) in HVC study
data. Bar-plot of availability (analog to Fig. 3.9) is not shown since no subjects had more than 40%
missing data over this 270 hour time period.
To select features for the HMM-FLDA sleep/wake segmentation algorithm over the full time
course of 0-270 hours, we designated two one hour periods of the day, 3:00-4:00 and 21:00-22:00,
respectively, as sleep and wake (resting). As contrasted to the pre-infection segmentation in which
we used 3 hour periods in the 60 hours (2 nights) of available data, here we could take advantage
of the higher specificity of one hour periods since 11 nights are available over the 270 hours. The
sleep/wake separability indices (SI), defined in (3.6), of each of the 12 temporally localized features
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were computed over all time points in order to evaluate their discrimination power. Figure 3.14
shows box-plots of the SWSI values for the 12 local features.
Four local features had SWSI greater than 0.7 for over over 75% of the subjects: HR MEAN,
HR MED, HR SD, ACC SD. Since HR MEAN and HR MED are highly correlated, HR MEAN
was excluded from the top 4 SI features as its 25% quantile is lower than that of HR MED. The
remaining features were then used as feature variables in the second stage of the pipeline to identify
sleep/wake sessions for each subject. Like in the 0-60 hour segmentation, we again note that the
EDA features have lower sleep/wake separability indices than the other E4 variables.
Figure 3.14: Box-plot of sleep/wake separability index (3.6) for full (0-270 hour) data, showing
the spread of the 12 temporally localized features extracted from wearable data in the first stage
(pre-processing) of the processing pipeline. Excluding HR MEAN, which is highly correlated with
HR MED and has smaller 25% quantile, three features (HR MED, ACC SD, HR SD) are selected
for training HMM-FLDA in the second stage of the pipeline.
Stage 2: adaptive segmentation The following table summarizes the results of applying ab-
normality classification (Fig. 3.12) in Stage 2 to the abnormal 10 min epochs identified by the
abnormality filter in Stage 1. For the purposes of illustration, the table is restricted to epochs falling
within the typical resting period (21:00 - 22:00) and the typical sleeping period (03:00 - 04:00).
The counts in the table represent abnormality classification over the full 270 hours of the HVC
experiment summed over the 20 subjects falling under the 0.4 abnormal proportion threshold in Fig.
3.14. The Normal category are the Wake and Active classes in Fig. 3.12 and represent epochs that
were re-inserted into the segmented event stream after termination of the HMM-FLDA algorithm.
No epochs in these one hour intervals were labeled as "Other."
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Total NW Loss-of-contact Normal
Resting (21:00-22:00) 1194 0 122 1072
Sleep (03:00-04:00) 1194 0 46 1148
Sensitivity of pipeline to tuning parameters Here we illustrate the lack of sensitivity of the
segmentation to our choice of two tuning parameters: epoch length δt and the number k of nearest
neighbors in the k-means classifier used for abnormality filtering.
Local optimality of selected epoch length for 0-270 hour data: To check the sensitivity of our
choice of 10 min epoch length δt we compared three different epoch lengths 5, 10 and 15mins, on
the full data (0-270 hours). Figure 3.15a shows a consensus criterion that is defined as the agreement
rate between the sleep/wake classifications of the HMM-FLDA pipeline using the 5, 10 and 15
minute epoch lengths, respectively. Figure 3.15a shows that the 10 min epoch length results in
sleep/wake labels that achieve the highest agreement rate. In this sense, δt = 10 mins. is locally
optimal for segmenting the 0-270 hour data. If other types of events are of primary interest, e.g.,
higher temporal resolution sleep stage analysis or sleep quality analysis, for which the presence of
outliers may be useful information, shorter epoch lengths might work better.
(a) (b)
Figure 3.15: (a) Box-plot of HMM-FLDA event label agreement rates between three different epoch
lengths showing that the choice of δt = 10 min comes closest to consensus. (b) Box-plotshowing
high agreement rates between abnormality detection based on marginal and multivariate k-means
clustering among all subjects.
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Choice of dimension in the k-means clustering used for abnormality filtering (0-270 hours):
In the context of the HVC data with the full 270 hours of data available, Fig. 3.15b compares
k-means clustering for different feature dimensions in the context of abnormality filtering described
in Sec. 3.6.4.1. Specifically, the case of multivariate k-means, where k-means is applied to local
feature vectors in their full 12 dimensions, is compared to the case of marginal k-means, where it
is applied to each feature dimension independently. For each subject we calculated the agreement
rate (percentage agreement) between the multivariate and marginal k-means implementation, where
agreement is defined as the number of times they agree that a time sample is abnormal over the
subject’s 270 hours of data. The box plot in Fig. 3.15b shows the distribution over the 25 subjects
and indicates that there is greater than 0.98 agreement rate for all but 3 subjects whose agreement
rates are all still greater than 0.95. Thus the simpler marginal k-means is virtually equivalent to the
multivariate k-means.
Example: abnormality filtering for two of the subjects (0-270 hours) For the purposes of
visualization of the differences between the features of subjects with usable and unusable data, we
show the results of principal components analysis (PCA) of two subjects in Figures 3.16a and 3.16b.
These figures show scatter plots of the first two principal components of all 12 temporally localized
features over the full 0-270 hour data. Both participants have clusters of outliers (grey colored
points falling on the right side of the figures) that were identified as non-normal by the abnormality
filter in our processing pipeline of Fig. 3.1b. For the subject in Figures 3.16b the non-normal data
corresponded to a HR and TEMP features that are highly abnormal (mean TEMP < 20oC and
mean HR > 160bpm) over long time periods, suggestive of a device that is either malfunctioning,
not being worn properly, or not being worn. This latter subject was one of the 5 subjects that was
eliminated from the analysis since more than 40% of all his time points were detected as abnormal.
For the subject in Figure 3.16a the detected non-normal data corresponded to a short time period
where the HR and ACC features exhibited high median and high standard deviation, suggestive of
a short session of intense physical exercise. This subject was included in the analysis since less
than 40% of the time points were detected as abnormal. For this subject, the abnormality classifier
described in Appendix 3.6.4.1 classified these non-normal data points as "Active," and, based on
their time stamps, inserted them into back into the corresponding wake session determined by the
HMM-FLDA procedure.
Example: segmentation results for two subjects (0-270 hours)
Figure 3.17 shows the sleep segmented data for two subjects with usable data (Subject 1 and
Subject 2 shown in Fig. 3.4) at the output of the pipeline of Fig. 3.1b when all time points (0-270
hours) of all subjects are available for processing.
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(a) (b)
Figure 3.16: (a) scatter plot of the first two PCs for a subject with usable data (abnormal proportion










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.17: Processed segmented time courses for Subjects 1 and 2 shown in Fig. 3.4 for the 3 event
classification features, HR median, ACC sd and HR.sd, color coded according to the abnormality
classification categoires: sleep, wake, active, not-worn (NW), loss-of-contact (LOC), and other
(Unknown). (a) segmented data from non-infected Subject 1; (b) segmented data from infected
Subject 2. 78
3.6.5 Clinical outcome prediction
Here we give additional information relevant to prediction of clinical outcomes, infection/non-
infection status and shedding onset time, as discussed in Section 3.4.
Recall that the pipeline produces high dimensional sleep/wake labeled features obtained as
statistical summarizations of the local E4 features. Two implementations are evaluated: offline and
online feature extraction. The offline implementation accesses the subject’s full data (all sampling
times, 0-270 hrs), using it to perform anomaly detection, HMM-FLDA sleep/wake segmentation
and feature extraction. The online implementation only has access to the pre-infection data (sample
times over 0-60 hours) to perform these operations. The offline and online versions of the pipeline
both ended up rejecting 5 of the subjects with excessive missingness and abnormality, and for each
non-rejected subject generates a set of features described in Table 3.3.
In Table 3.7 are shown the distribution of subjects over the clinical outcomes, in the separate
categories of infection status and infection onset time. Here infection status is the binary outcome
that a subject will or will not shed virus over the course of 270 hours of the confinement phase of
the challenge study. Infection onset time is a ternary response variable indicating the categories
"Early onset" (shedding begins on day 4), "Late onset" (shedding begins on day 5), and "No onset"
(shedding not detected on any day).
The 1st row of Table 3.7 shows numbers of subjects in each infection category among all 25
subjects having E4 data records. The 2nd row shows the same statistics for the 20 subjects with
sufficient quantity and quality data as determined by the missingness and abnormality filtering
implemented by the offline feature extraction pipeline having access to the full time course (0-270
hrs). The 3rd row shows these statistics for the 20 subjects with sufficient quantity and quality data
determined by the online feature extraction pipeline (0-60hrs).
Note that the classes are moderately well balanced for the binary infection status class but are
unbalanced for the ternary shedding onset time, with the early class having only 2 or 3 subjects. We
address this class imbalance using a compensation method in Section 3.6.5.
To assess the value of each of the 196 features for predicting clinical outcomes in Table 3.7
to types of univariate classifiers were implemented on each feature and their performance was
evaluated using the area under the receiver operating characteristic (ROC) curve.
For classifying the binary infection status the logistic regression (LR) classifier was implemented.





= β0 + β1X ,
where logit(x) = log[x/(1− x)], y ∈ {0, 1} is the shedding status, and X is one of the 196 features
produced by the pipeline.
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Table 3.7: First row: infection status shedding onset time of all 25 subjects having E4 data records.
Second row: infection status of the 20 subjects with sufficient non-anomalous data over 0-270 hours
as determined by the offline feature extraction pipeline having access to the full time course data
(0-270 hours). Third row: infection status of the 20 subjects with sufficient non-anomalous data as
determined by the online feature extraction pipeline having access only to the pre-infection time
course data (0-60 hours).
Subject group
Infection Status Shedding onset time
Infected Not infected Early Late No onset
25 subjects w/ E4 data records 11 14 3 8 14
20 subjects w/ sufficient data (0-270 hrs) 8 12 2 6 12
20 subjects w/ sufficient data (0-60 hrs) 9 11 3 6 11
For classifying the onset time we fit a continuation-ratio (CR) regression model [Agr10] to the
conditional probability P (Y = y|Y ≥ y), where y = 1 for early shedders, y = 2 for late shedders
and y = 3 for no onset (non-) shedders). This becomes an ordinal censured response model when
"no onset" is identified as onset at infinity. Mathematically, the continuation ratio is a logistic
regression model for this conditional probability:
logit
[
Pr(Y = y |Y ≥ y)
]
= β0 + β1X ,
for y = 1, 2, 3.
3.6.5.1 Clinically discriminating features: online pre-infection timecourse feature extrac-
tion
We emulate online implementation of the feature extraction pipeline for infection status predic-
tion by applying the pipeline to only the pre-infection timecourse (0-60 hours). In this case, only
the first 60 hours affect the sleep segmentation and the sleep features. Some of the 196 resulting
sleep/wake features in Table 3.3 are useful for predicting the the clinical outcome, i.e., infection
status, of exposure to the viral challenge. Table 3.8 shows the ten top ranking features for predicting
infection vs. non-infection (left column) and for predicting infection onset (right column) where the
predictors use features from inoculation day only. To obtain the rankings on the left column of the
table, the AUC attained by the univariate logistic regression (LR) was computed using leave-one-out
cross validation (LOOCV) on the 20 subjects who were not filtered out by Stage 1 of the pipeline,
i.e., these subjects do not have excessive missingness or abnormal samples. We also include the
Accuracy (average classification error), computed using the same LOOCV procedure as used for
computing AUC. Observe that the top 3 features ranked by accuracy are sleep features. Feature
rankings by Accuracy and AUC are not the same since AUC is more stringent as it measures
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accuracy over the full range of sensitivities and specificities of the LR model. The right column of
the table is obtained by ranking the features in decreasing order of min {AUC(Early), AUC(Late),
AUC(No onset)}.
Table 3.8: Top 10 E4 sleep/wake features capable of predicting clinical outcome (shedding) using
only the extracted features from inoculation day (day 2) when these features are obtained from the
online implementation of HMM-FLDA, for which only pre-infection data (0-60 hrs) is available to
the HMM-FLDA procedure.
logistic regression model continuation-ratio regression model
Feature Coef. Accuracy AUC Feature Coef.
AUC
Early Late No onset
HR MED.sd (sleep) -3.921 0.842 0.758 HR MED.sd (sleep) -5.073 0.882 0.718 0.864
ACC SD.linear.coef1 (wake) -14.468 0.750 0.737 HR MEAN.sd (sleep) -4.466 0.706 0.628 0.773
HR MED.quad.coef2 (sleep) 4.318 0.789 0.707 Total duration -0.599 0.676 0.551 0.750
Offset -1.452 0.789 0.697 Night duration -0.616 0.647 0.500 0.705
EDA MED.linear.coef0 (wake) 0.802 0.600 0.697 ACC MEAN.sd (sleep) -2.303 0.500 0.449 0.602
EDA MEAN.linear.coef0 (wake) 0.815 0.650 0.687 Offset -0.774 0.618 0.436 0.750
HR MEAN.sd (sleep) -4.077 0.632 0.677 ACC SD.linear.coef1 (wake) -10.394 0.412 0.679 0.747
HR MED.linear.coef0 (wake) 0.117 0.650 0.677 HR MEAN.linear.coef0 (wake) 0.091 0.412 0.488 0.646
Total duration -0.655 0.632 0.667 ACC MEAN.linear.coef1 (wake) -13.907 0.412 0.512 0.636
HR SD.quad.coef2 (sleep) 3.949 0.737 0.646 HR SD.sd (sleep) -1.831 0.471 0.410 0.568
Figures 3.18 and 3.19 show box-plots of the four top features in Table 3.8 for logistic regression
and continuation ratio regression stratified over shedders and non-shedders.
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Figure 3.18: Boxplot of top 4 features for predicting binary infection status using univariate logistic
regression on the 196 sleep/wake features on the day of inoculation (day 2) obtained from online
HMM-FLDA, which only has access to pre-infection data (0-60 hrs).
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Figure 3.19: Boxplot of top 4 features for predicting ternary infection onset time using univariate
continuation ratio regression on the 196 sleep/wake features on the day of inoculation (day 2)
obtained from online HMM-FLDA, which only has access to pre-infection data (0-60 hrs).
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3.6.5.2 Clinically discriminating features: offline full timecourse feature extraction
In the offline implementation, the full timecourse (0-270 hours) is provided to the pipeline for
sleep/wake segmentation and the session-level feature set depends on all past and future time points.
To these features we trained the same LR and CR infection status classification algorithms status
as in the online implementation described above. Table 3.9 shows the top 10 features in terms of
maximizing the AUC. Many of the features in this offline table are similar to the features found by
the online implementation shown in Table 3.8. The offline AUC tends to be higher than the online
AUC in Table 3.8, possibly due to improved wake/sleep segmentation when more data is available
for training (270 hours of data instead of 60 hours of data).
Table 3.9: Top 10 E4 sleep/wake features capable of predicting clinical outcome (shedding) using
only the extracted features from inoculation day (day 2) when these features are obtained from
the offline implementation of HMM-FLDA, for which the full data (0-270 hrs) is available to the
HMM-FLDA procedure.
logistic regression model continuation-ratio regression model
Feature Coef. Accuracy AUC Feature Coef.
AUC
Early Late No onset
HR MED.sd (sleep) -6.196 0.750 0.833 HR MED.sd (sleep) -7.195 0.944 0.631 0.844
Offset -1.629 0.650 0.802 Total duration -1.139 0.750 0.619 0.813
Total duration -1.211 0.750 0.781 HR MEAN.sd (sleep) -4.597 0.667 0.595 0.750
HR MEAN.sd (sleep) -4.958 0.650 0.750 Night duration -0.854 0.667 0.560 0.698
Night duration -0.896 0.600 0.688 Offset -0.864 0.611 0.488 0.802
HR MED.mean (wake) 0.147 0.750 0.625 HR MED.mean (wake) 0.154 0.472 0.619 0.646
HR MED.median (wake) 0.149 0.750 0.625 HR SD.sd (sleep) -1.877 0.500 0.464 0.573
HR MEAN.median (wake) 0.142 0.750 0.615 HR MED.median (wake) 0.150 0.444 0.595 0.625
ACC SD.linear.coef1 (wake) -7.160 0.550 0.615 HR MEAN.mean (wake) 0.151 0.417 0.607 0.635
HR MEAN.mean (wake) 0.141 0.750 0.604 HR MEAN.median (wake) 0.142 0.417 0.607 0.625
Figures 3.20-3.24 show box-plots of the top 5 top logistic regression features (first column) in
Table 3.9 stratified over shedders and non-shedders.
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Figure 3.20: HR MED.sd (Standard deviation of median heart rate) sleep feature generated by
the proposed HMM-FLDA pipeline when implemented offline, i.e., the HMM-FLDA sleep/wake
segmentation is computed assuming availability of the full time course (0-270 hours) human viral
challenge study (HVC) data. Viral inoculation took place on day 2 and all viral shedders started
shedding on day 4 or day 5. Note that, as compared to the non-shedders, the shedders tend to have
lower sleeping heart rate variation in the first two days.
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Figure 3.21: Sleep offset (wakeup time from night sleep) feature generated by the proposed
HMM-FLDA pipeline when implemented offline, i.e., the HMM-FLDA sleep/wake segmentation is
computed assuming availability of the full time course (0-270 hours) human viral challenge study
(HVC) data. Viral inoculation took place on day 2 and all viral shedders started shedding on day
4 or day 5. Note that, as compared to the non-shedders, during the first 8 days of the study the
shedders tend to wake up earlier than the non-shedders.
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Figure 3.22: Total duration (the sum of all night and day sleep hours) sleep feature generated by
the proposed HMM-FLDA pipeline when implemented offline, i.e., the HMM-FLDA sleep/wake
segmentation is computed assuming availability of the full time course (0-270 hours) human viral
challenge study (HVC) data. Viral inoculation took place on day 2 and all viral shedders started
shedding on day 4 or day 5. As compared to the non-shedders, the shedders tend to have a sleep
deficit until the 7th day.
Figure 3.23: HR MEAN.sd (standard deviation of the heart rate mean) sleep feature generated by
the proposed HMM-FLDA pipeline when implemented offline, i.e., the HMM-FLDA sleep/wake
segmentation is computed assuming availability of the full time course (0-270 hours) human viral
challenge study (HVC) data. Viral inoculation took place on day 2 and all viral shedders started
shedding on day 4 or day 5.
87
Figure 3.24: Night sleep duration feature generated by the proposed HMM-FLDA pipeline when im-
plemented offline, i.e., the HMM-FLDA sleep/wake segmentation is computed assuming availability
of the full time course (0-270 hours) human viral challenge study (HVC) data. Viral inoculation
took place on day 2 and all viral shedders started shedding on day 4 or day 5. As compared to the
non-shedders, the shedders tend to have a night sleep deficit until the 7th day. Compare to the total
duration of sleep feature shown in 3.22 that includes duration of both night-time and daytime sleep.
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3.6.5.3 Extensions of marginal clinical outcome predictor
Two extensions to the univariate regression framework for clinical outcome prediction are pre-
sented here. First a multivariate logistic regression and continuation ratio classifier are implemented
on the top three univariate features for the full timecourse segmentation data. Then we apply a
method that improves (univariate or multivariate) classifier performance for data with imbalanced
class sizes.
Multivariate classifiers When the top three univariate logistic regression features in Table 3.9
(HR MED.sd, offset and total duration) are combined into a single model, the multivariate logistic
model achieves AUC = 0.844, and the continuation-ratio model achieves AUC = 0.885 for
classifying “Late shedder versus others.” This represents only a moderate improvement relative to
the corresponding marginal AUC’s listed in the table.
Table 3.10 shows the Pearson correlation between the 3 features having maximum marginal
area-under-the-curve (AUC) of the receiver operating characteristic curve (ROC) for classifying
clinical outcome, presented in Section 3.4. The presence of significant correlation between feature
over the population explains why multivariate LR and CR classifiers of clinical outcome can only
attain marginally better AUC than do the univariate LR and CR classifiers.
Table 3.10: Pearson correlation coefficients (p-values) between top 3 features selected using AUC
criterion for univariate logistic regression and continuation ratio classifiers of clinical outcome.
Total duration Offset HR MED.sd
Total duration 1 0.778 (< 0.001) 0.434 (0.056)
Offset 1 0.485 (0.030)
HR MED.sd 1
Imbalanced class sizes : It is well known that imbalanced class size in the training data can
negatively affect performance, especially for the under-represented classes. To mitigate the impact
of these imbalanced shedding class sizes, we applied the synthetic minority over-sampling technique
(SMOTE) [CBHK02] to rebalance the class sizes. SMOTE is a method for equalizing minority
class sizes by introducing synthetic data samples that rebalances to match the majority class size. It
does this rebalancing as follows. First a feature instance x is randomly selected from the minority
class. Then for this point x the k minority class nearest neighbors {xi}ki=1 are identified. One
of these nearest neighbors xR is selected as random and a random variable U is drawn from the
uniform distribution over [0, 1]. Finally, the new SMOTE point in the minority class is defined as
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s = x+ U ∗ (xR − x). This process is repeated until the minority class has as many samples as the
majority class.
SMOTE can be applied to any classifier but can be expected to work best when the classification
regions are convex in feature space. SMOTE is commonly applied to cases where the class imbalance
is moderately small, e.g., the ratio of the smallest to largest class sizes is greater than 0.5. For the
HVC data, Table 3.7 indicates that for the binary infection status outcome the imbalance is moderate
(class size ratio > 2/3) but for the ternery infection onset outcome the imbalance is severe (class
size ratio can be as low as 1/3).
First we considered compensation of class imbalance in the univariate logistic and continuation
ratio regression predictors of shedding and shedding onset 24 hours before any subject starts to shed
virus. SMOTE was applied using k = 3 nearest neighbors for each minority class except for the
early onset shedder group where only 1 nearest neighbor was used since this group only contains 2
or 3 samples. Since SMOTE is a randomized algorithm, 100 SMOTE runs were performed. Recall
that HR MED.sd was the top ranked feature for both LR and CR and for both the full data and the
pre-infection data.
We implemented SMOTE for LR and CR on the univariate predictor using HR.MED.sd and on
the multivariate predictor using HR.MED.sd, Total Duration and Offset. We considered both the
offline case (sleep/wake segmentation was performed by FLDA using the full data, 0-270hrs) and
the online case (sleep/wake segmentation was performed by FLDA using only the pre-infected data,
0-60hrs).
The first 3 rows and the last 3 rows of Table 3.11 shows the Accuracy (average classification
error rate) and the AUC for logistic regression (LR), and the AUC for continuation ratio regression
(CR) in the univariate case. The right columns of the table indicate significant AUC performance
improvement for CR, for which class size is severely imbalanced (P-VALUE is the result of double
sided paired t-test). In the case of the LR, on left side of table, the class imbalance is not as severe
and SMOTE leads to no improvement in AUC or Accuracy for the univariate case. Indeed, SMOTE
compensated univariate LR has worse Accuracy (p-value < 0.01 according to double sided t-test)
when either offline or online sleep/wake segmentation is used.
The middle 3 rows of the table show the results of applying SMOTE to multivariate logistic and
continuation ratio regression for the offline case. For multivariate CR, SMOTE improves the AUC
(p-value < 0.01 according to double sided t-test). For multivariate LR, SMOTE improves the AUC
and the Accuracy only in the offline case.
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Table 3.11: SMOTE compensation for imbalanced sample size for predictors of shedding and
shedding onset time 24 hours before first shedding occurs.
Feature(s)
LR CR AUC
Accuracy AUC Early Late No onset
Offline training
(FLDA trained on 0-270hrs)
HR MED.sd (sleep)
w/o SMOTE 0.750 0.833 0.944 0.631 0.844
SMOTE
MEAN 0.703 0.846 0.951 0.656 0.907
P-VALUE 4.68E-11 0.015 1.38E-06 6.68E-07 2.80E-56
Total duration + Offset
+ HR MED.sd (sleep)
w/o SMOTE 0.800 0.844 0.889 0.655 0.885
SMOTE
MEAN 0.838 0.865 0.974 0.811 0.937
P-VALUE 2.21E-21 6.78E-35 1.66E-71 3.28E-83 1.38E-75
Online training
(FLDA trained on 0-60hrs)
HR MED.sd (sleep)
w/o SMOTE 0.842 0.758 0.882 0.718 0.864
SMOTE
MEAN 0.781 0.727 1.000 0.751 0.899
P-VALUE 8.23E-13 3.00E-03 - 5.98E-06 1.69E-25
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CHAPTER 4
Cognitive Performance Variability is Associated with Susceptibility to
Infection
4.1 Introduction
Cognitive function and other psychological factors (e.g. stress) have long been associated with
physiological health. In particular, reaction time, vigilance and processing speed are central to the
human ability to perform optimally. Accumulating evidence suggests that intra-individual variability
in reaction time (and other cognitive domains) may reflect neurobiological disturbance and have
valuable prognostic significance [Sal07]. Higher variability of reaction time has been associated
with greater mortality over 19-years of follow up in both younger and older adults as well as risk
for falls and neurodegenerative disorders [SDTD06, HBB17].
Cognitive function is also closely linked to immune health and there is increasing recognition
that immune cells play a physiological role in cognition and stress response [KGD12]. For example,
T-cells have been reported to have a pro-cognitive effect and neurotransmitters involved in the
immune response, such as acetylcholine, dopamine and noradrenaline, also play a key role in
cognition [KGD12]. In healthy aging adults, elevated concentrations of pro-inflammatory cytokines
has been linked to worse cognition [SMRS+20]. This relationship is further reflected by the fact
that many of the same factors that impair immune response (e.g. sleep deprivation, stress, alcohol
consumption, depression, infections) also impair cognitive performance.
We therefore tested the hypothesis that intra-individual variability in vigilance and reaction time
measured over a 3 day baseline, reflecting subtle changes in immune and brain health, would predict
vulnerability to a common infection.
More specifically, in the context of a longitudinal human viral challenge study we establish
associations between pre-exposure cognitive function and post-exposure immune response, as
measured by various markers, such as severity of symptoms and viral shedding. Among the many
pre-exposure cognitive markers that we study we find that it is a new measure, called the cognitive
performance variability (CPV), that is the most correlated to immune response. The CPV is extracted
from a person’s performance on a sequence of NeuroCognitive Performance Tests over several days
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leading up to exposure. The NeuroCognitive Performance Test (NCPT) uses 4 interactive games
to measure a person’s cognitive performance along 18 dimensions. These 18 NCPT variables are
shown in Table 4.1a). The CPV score is a measure of the person’s cognitive dissonance over time
along any dimension. Unlike other measures of variability, like the linear coefficient of variation
(CoV), the CPV is a non-linear max-pooled measure of variability of the NCPT variables.
Our findings rely on analysis of a week-long viral challenge study in which cognitive function of
non-quarantined volunteers were monitored three times a day over a one week period using NCPT
and other cognitive tests. On the fourth day the participants were inoculated with a viral pathogen;
the common cold (HRV). The CPV was computed from NCPT data collected three times a day
over the pre-exposure time period and the amount of viral shedding was computed from PCR data
collected daily over the post-exposure time period.
The main contribution of this paper is the demonstration that a certain kind of cognitive
variability measure, the aforementioned CPV score computed from pre-exposure data, has an
uncommonly strong association with a subject’s amount of post-exposure viral shedding. Our
findings are supported on several pillars. First, we find that the Pearson correlation of CPV and
shedding is near 0.9, that the R2 linear regression goodness of fit is near 0.8, and the AUC for
detecting post-exposure shedding above the median is near 1. The NCPT scores that contribute the
most to the CPV are the Posner Tutorial Time, DigSym Time, DigSym Correct, Trail Time, and
Reaction Time. The subjects that have high variability in at least one of these scores tend to have
high levels of viral shedding after exposure.
As a point of comparison, the proposed CPV score achieves significantly better performance
than that attainable using the standard coefficient of variation (CV), whose correlation with shedding
is less by factor of two (Pearson correlation −0.42 compared to 0.88). We find that there is little
value in supplementing the NCPT variables with other cognitive variables in the CPV score. These
variables included pre-exposure sleep duration and the visual analog fatigue score (VAFS). This
finding is consistent with the fact that the NCPT-only CPV score is correlated with these other
variables (Figure 4.10 in supplementary material).
To probe the effect of reducing the number and timing of the NCPT test sessions, we performed
a combinatorial cross-validation study of the influence of both the number of sessions and session
timing on the CPV. Our findings indicate that CPV vs shedding correlation above 0.69 can be main-
tained with as few as T = 5 sessions as long as there is at least one session per day. This suggests
that cognitive performance variability markers may have practical clinical and epidemiological
application.
In Section 4.2 we state our main findings, followed by a Materials and Methods Section 4.3
where we present details on our methods. We continue with a Discussion Section 4.4 where we
discuss these results and methods. Finally in the Conclusions Section 4.5 we summarize the paper
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and comment on future work. The Supplementary Material 4.6 accompanying this paper contains
further data on our methods and findings, as discussed below.
4.2 Results
A longitudinal viral challenge study was performed in 2015 in which 18 human volunteers
participated over a period of 9 days. On the fourth day of the study participants were inoculated
with HRV virus (the common cold) and the participants’ daily viral shedding was collected for
the remainder of the study. The cognitive function of the volunteers was collected three time per
day over the pre-exposure days and the time series of 18 NCPT variables listed in Table 4.1a was
transformed to a CPV score for each participant (see Materials and Methods).
Our main results are shown in Figure 4.1 which shows each participant’s CPV scores computed
after omitting the initial NCPT session (screening session). Figure 4.1c shows a remarkably strong
association between total amount of post-exposure shedding and cognitive performance variability,
as measured by the CPV score, for each individual. The Pearson correlation is 0.88 with 95%
confidence interval [0.69, 0.95]. A linear regression of total shedding onto the CPV score gave
an R2 of 0.77 . Furthermore, a logistic regression of total shedding onto the CPV score yielded
a perfect discriminant between high and low shedders, respectively defined as those whose total
shedding is below versus above the population median.
To illustrate the role of the 18 individual NCPT variables in the CPV, we plot in Fig. 4.1d the
univariate CPV scores for the two lowest shedding and the two highest shedding participants. This
figure is extracted from Figure 4.16 in the Supplementary Material that shows the sequence of
univariate CPV scores for all 18 study participants. Superimposed on the plot of these variables is a
boxplot indicating score sensitivity to session perturbation, determined by leave-one-out analysis
where the univariate CPV was recomputed after successively leaving a single NCPT session out of
each participant’s sequence (sans screening session). Figure 4.1d clearly shows that certain NCPT
variables have significantly higher variability for the high shedders (lower two panels) than for
the low shedders (top two panels). Note that the NCPT variable with highest variability (variable
achieving peak score in each panel of Figure 4.1d) differs across study participants.
To explore the effect of reducing the number of cognitive testing sessions and their timing, we
performed a combinatorial study of the association between shedding and CPV as we vary both
the number of NCPT sessions and their associated timing patterns over the baseline time period.
As the number of sessions ranging from T = 3 to T = 10, Fig. 4.2 shows the top ten patterns,
ordered in decreasing Pearson correlation, and their associations to infection severity as measured
by correlation, R2 and AUC. The results of the full combinatorial study are given in Fig. 4.17, and
the zoomed-in figure, Fig. 4.18, in the Supplementary Materials.
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The connection between NCPT variables and gene expression would be interesting to investigate.
We performed a Pearson correlation test to screen the genes significantly correlated with NCPT
variables. The number of significant genes and the name of gene with smallest p-value is included
in Table 4.19. There are 3, 726 genes significantly correlated with digSym-error, far more than
reaction-time, which ranked second with 155 correlated genes. 6 NCPT variables is not significantly
correlated with any gene. ADGRG7 has been repeated found to be the most significantly correlated
gene with 6 NCPT variables. ADGRG7, GLYATL2 and PNMAL1 are also correlated with 7 NCPT
variables. A pathway enrichment analysis was performed to understand the genes significantly
correlated with the NCPT variables. The result is shown in Table 4.20. The most significant pathway
is Phagosome with FDR 3.99e-3. Many members in MAPK family are targeted in the enriched
pathways.
4.3 Materials and Methods
4.3.1 Challenge study protocol
Viral shedding and cognitive performance data were collected from a human rhinovirus (HRV)
challenge study. A total of 24 volunteers were recruited and 19 participated in the study. One
of these participants had a failed inoculation and was omitted from our analysis. The age range
of the remaining 18 participants was between 18 and 23, two thirds of these participants were
male, and 4 were non-caucasian. For a more detailed demographic summary see Fig. S1 of the
Supplementary Materials. The study was reviewed and approved by the Institutional Review Boards
at Duke University and at University of Virginia . Written informed consent was obtained from all
participants. Exclusion criteria included pregnancy, chronic respiratory illness, high blood pressure,
tobacco/drug/alcohol history, and serum antibody levels above 1:4 titers. The participants were not
isolated during the study.
The challenge study lasted 9 days over which various types of biomarkers were continuously
collected from participants using wearable wristbands (Empatica E4), whole blood assays (mRNA,
p180 metabolites, steroids), nasal-pharyngal washes (viral shedding), cognitive testing (Lumos),
and self-reported clinical data (symptoms). On day four at 8am (80 hours) each participant
was inoculated via intranasal drops of diluted Human Rhinovirus strain type 16 with a dose of
100TCID50 in 1mL Lactated Ringer’s Solution.
After inoculation the participants underwent daily nasal lavage each morning to determine the
amount of viral shedding. Figure 4.3a shows the total amount of shedding for each participant
over all post-inoculation study days, ordered from maximum to minimum. Cognitive scores were
collected from test sessions 3 times per day in the morning, mid-day, and in the evening (Fig. 4.3b).
This data was also collected from a reference session prior to the start of the study. In each session
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the participant answered web-based questionnaires and engaged with Lumos brain testing software
using computer tablets that were provided to them.
4.3.2 NeuroCognitive Performance Test
The NeuroCognitive Performance Test (NCPT) is a repeatable, web-based, computerized,
cognitive assessment platform designed to measure subtle changes in performance across multiple
cognitive domains [MSNH15]. It comprises of 18 subtests and the modular platform allows
for customized subtest batteries for specific studies. It was formerly referred to as the Brain
Performance Test. As such computerized tests may offer several advantages over traditional paper
and pencil methods, such as greater consistency in administration and scoring, generation of
alternate forms for repeated testing, precise stimulus control, ability to capture and analyze multiple
components of a test taker’s response, adaptation of difficulty levels, greater convenience and
ability to administer at different settings. Test reliability and concurrent validity of the NCPT for
unsupervised administration has been previously published. Specifically, the authors of [MSNH15]
reported normative data for more than 130,000 individuals aged 13–89 years as well as data on the
ability of NCPT to detect mild cognitive impairments.
The specific NCPT battery used in the study comprised of four subtests designed to measure
attention, processing speed, response inhibition and cognitive load (task switching and executive
function) – domains known to be sensitive to fatigue, stress and infections [Smi12]. The brief
battery (15 minutes) was designed to be easy to complete and included the four subtests described
below:
1. Attentional Cueing (Posner): A measure of selective attention and processing speed. An
arrow cue is shown followed by a stimulus placed in one of 2 locations. Subjects pick the
correct location of the stimulus.
2. Digital Symbol Coding: A measure of attention/vigilance, speed and immediate memory.
Subjects enter the number corresponding to randomnly generated symbols using a key at the
top of the screen in 90 seconds. The primary measure is number of correct responses minus
number of incorrect responses.
3. Go/No-Go: A measure of response inhibition and processing speed. Participants were
required to respond as quickly as possible to a target, but to avoid responding to distractions.
4. Trail Making B: A measure of executive function, speed and mental flexibility. Subjects
connect the numbers from smallest to largest alternating between numbers and letters. The
primary measure is completion time and there is no time limit.
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These 4 subtests yield 18 scores related to speed, accuracy and congruency. The tests were
administered at 10 time points across 3 days at baseline. Raw scores on all 18 tests across all 10
time points were used to compute the cognitive variability indices.
In addition to NCPT, several well established self-reported psychometric markers were measured
at various times in the study. This included responses to fatigue related questions using two protocols:
the Visual Analog Fatigue Scale (VAFS), measured 3 times per day; and the Fatigue Severity Scale
(FFS), measured at screening and on the fourth day of the study. The VAFS is a response to a
single question scoring fatigue from 10 (no fatigue) to 0 (severe fatigue), while FFS is comprised of
responses to 9 fatigue-related questions. A large scale clinical validation study of these measures of
fatigue was reported in [KLMNS89]. The Perceived Stress Scale (PSS) was used to measure stress
at the initial screening session. The PSS is an instrument that measures a person’s perceived stress
over the past month consisting of 10 questions about stress on a scale of 0 to 4, which has been
clinically validated in [CKM83]. Finally, the reduced Composite Scale of Morningness (rCSM)
was used to measure an individual’s chronotype. The rCSM consists of a subset of 7 questions from
the set questions of the full CSM [SRM89] on the most productive part of the day. The rCSM has
been clinically validated in [Ran09].
4.3.3 Cognitive Performance Score (CPV)
The CPV is computed as follows. For a particular participant i and cognitive variable j, e.g.,
NCPT reaction-time, let the value of the variable at them-th session time be xij(m),m = 1, . . . , Nij ,
where Nij are the number of time samples, e.g, number of NCPT sessions, prior to inoculation time.
In Eq. [4.1] we define the statistic Tij ∈ [0, 1]. In this equation, x+ij = (Nij − 1)−1
∑Nij
m=2 xij(m)
and x−ij = (Nij − 1)−1
∑Nij−1




The univariate CPV for the i-th subject and j-th variable is defined as the quantity:



















where B(x; a, b) is the incomplete beta function









The CPV can be interpreted as the −log of the reported p-value of a significance test of change
of mean in successive pairs of values xij(m), xij(m − 1), m = 2, . . . , Nij . Specifically, CPVij
can be obtained by applying the one-sided ANOVA significance testing procedure [Sch99] to the
columns of the matrix
Xij =
[
xij(1) . . . xij(Nij − 1)
xij(2) . . . xij(Nij)
]
.
This mathematical equivalence allows us to compute the CPV using standard ANOVA software
(Matlab R2020a anova1.m).
4.4 Discussion
Empirically we see from the heatmap in Fig. 4.1 that five of the 18 cognitive scores contribute the
most to the CPV: digSym-correct, digSym-time, reaction-time, trail-time, and posner-tutorialTime.
It is interesting that 4 out of the 5 are time-to-completion features and only only one of them is a
correctness feature.
The game-playing learning curves cannot alone explain the high associations between CPV
and total shedding. A learning curve of each participant was extracted and it had no significant
correlation to total shedding (Supplementary Materials).
The CPV was much more highly correlated with shedding titers than are other factors that have
been previously related to susceptibility to infection, e.g., self-reported fatigue (VAFS), self-reported
stress, or hormonal stress indicators (cortisol). See the correlation matrix Fig. 4.10 in Supplementary
Materials. Furthermore, no significant correlation between CPV and time-of-day was observed.
The combinatorial study shown in Fig. 4.2 indicates interesting structure in the session patterns
that guarantee high correlation between the CPV and viral shedding. As might be expected, the
association tends decrease as the number of sessions decreases, and when the early initial screening
session at time T = 1 is omitted. Furthermore, eliminating late sessions that are closer to exposure
time (T closer to 10 than to 1) tend to degrade the high association more than eliminating early
sessions. Interestingly, up to two successive sessions can be eliminated (roughly corresponding to a
gap of 16 hours between tests) without reducing correlation below 0.69. In fact, for T = 7 the best
way to omit sessions is to remove the session at T = 1 and eliminate the other two successively
between T = 3 and T = 9. A correlation greater than 0.69 (AUC > 0.8) is attainable even for as
few as T = 5 sessions as long as the they are distributed such that there is at least one test on each
of the three pre-exposure days.
The association between NCPT variables and gene expression is intriguing. One of the most
correlated genes, ADGRG7, encodes G protein-coupled receptor 128 (GPR128), a member of
adhesion G protein-coupled receptor. Although there is no direct evidence connecting GPR128
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and cognitive function, another member from the same family, GPR110, was reported to have
a role in cognitive function [LHK+16]. Many of the enriched pathways contain MAPKs and
dysregulation of the RAS/MAPK signaling cascade has been reported to have a role in cognitive
profile of disorders [CAP+09]. These findings suggest an interesting temporal connection between
NCPT variables and gene expression, and this observation might shed light on using non-invasive
cognition measurements to replace invasive and expensive gene expression test in certain cases.
These findings raise the intriguing possibility that periodic cognitive testing for assessing
susceptibility to severe infection may have clinical and/or epidemiological value. However, there
are several factors that might impede translation of our results to the clinic or to public health.
First, continuous testing over time would be necessary as the time of viral exposure cannot be
anticipated. This could possibly be overcome if our results extended to a rolling window version
of CPV and to more convenient cognitive stimuli than NCPT, e.g., derived from interactions with
a cell-phone. Second, the effect of a person’s adaptation (learning curve) to the cognitive stimuli
(NCPT) could not be determined in the relatively short 3 day baseline of our study. Third, it is
unknown whether our results would replicate for a different pathogen or for a cohort of participants
more representative of the general population (age, occupation, medical history).
As in any observational study, there are limitations to our findings. These include: 1) The small
sample size of the study, giving fairly wide (> 0.2) confidence intervals on the 0.88 correlation
reported; 2) Deviations of individual participant behaviors from the cognitive testing protocol: 4 of
the 18 participants completed fewer than 10 NCPT sessions and 2 participants did not participate
in the NCPT early screening session. Furthermore, some participants did not abide strictly to the
NCPT session timing (early morning, mid-day and evening). 3) As an observational study, we can’t
establish that CPV or any of its correlates are causal factors for increased viral shedding; but the
reported associations suggest that cognitive performance variability deserves further study in the
context of disease susceptibility.
4.5 Conclusions
Using data from a 9 day viral challenge study, this paper established a strong association between
pre-exposure variability of cognitive function and severity of infection, as measured by total viral
shedding after a person’s exposure to the common cold. A person’s cognitive variability over time
was measured using thrice daily NCPT brain testing, quantified with a score function related to
a one sided ANOVA test of significance. Our results suggest that regularly collected cognitive
performance markers may be useful for predicting shedding susceptibility, with potential clinical
and epidemiological application.
It is to be emphasized that the proposed cognitive performance variability (CPV) score is a fixed
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function without any tunable parameters. Such a parameter-free score does not require fitting any
model to population, unlike regression-based scores, and thus there is no overfitting error. However,
if we had access to a larger sample population or a longer baseline for training, it is possible that
we could improve on the CPV score by introducing some parameters. For example, we could fit
a regression model with variable selection to the population, selecting the most important NCPT
variables along with the regression coefficients. As another example, with a longer baseline, a
temporal dependency weighted CPV model might be fitted to each subject, e.g., accounting for the
effects of learning curves and circadian fluctuations.
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(b) Heatmap of 18 univariate CPV scores vs 18
participants.
(c) Post-exposure shedding vs pre-exposure CPV
score.




































(d) Univariate CPV scores for low (top) and high (bottom)
shedders.
Figure 4.1: Pre-exposure cognitive performance variability (CPV) is strongly associated with post-
exposure viral shedding. (a) Definition of 18 NCPT variables measuring subject performance on 4
different games: Digital Symbol Coding (DigSym), Go/No-Go (Reaction), Trail Making (Trail)
and Attention Cuing (Posner). (b) Heatmap of univariate CPV scores for each study participant
(ordered from highest to lowest amounts of post-exposure shedding). (c) Scatterplot of CPV and
shedding (Titer) for all 18 participants taking into account all post-screening and pre-exposure
NCPT sessions. The high Pearson correlation of 0.88 suggests that the CPV score might be used as
a marker of a person’s susceptibility to severe infection and that periodic cognitive testing might be
used for early prediction of infection severity. (d) Boxplots of the univariate Cognitive Performance
Variability scores over the 18 NCPT variables in Table 4.1a for two of the lowest shedding (top
row) and two of the highest shedding (bottom row) challenge study participants. The Solid blue
curve denotes the CPV scores computed for each NCPT variable using the full session sequence,
but omitting the reference session (earliest sessions Fig. 4.3b). Red boxplots show the distribution












































































(a) CVP association vs. session pattern.
Session frequency. Min corr=0.69. #sessions=105
(b) Session selection frequency.
Figure 4.2: Lumos session timing patterns corresponding to the 15 highest CPV vs shedding
correlations. Left: Boxplots of association measures between CPV and shedding for which the
cross-validated (leave-one-subject-out) CPV Pearson correlation coefficients are at least 0.69 (the
lower endpoint of 95% CI of correlation in Fig. 4.1c). The measures of association are the Pearson
correlation coefficient ρ, the R2 of linear regression, and the AUC of logistic regression of titers
with respect to CPV. The AUC measures the association of CPV with Low vs High shedding (0,1)
labels, where Low and High denote shedding below or above the population median, respectively.
The pattern heatmap at bottom indicates the corresponding timing patterns of Lumos sessions with
Time 1 corresponding to the initial screening and Time 10 corresponding to the test right before
exposure. The number of sessions in each pattern is denoted by T , fewer than T = 7 sessions
significantly reduces the association. Right: relative frequency of inclusion of particular session







m=2(xij(m)− xij(m− 1))2 + (Nij − 1)
∑Nij
m=2(xij(m)− x+ij) + (xij(m− 1)− x−ij))2
(4.1)
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(a) Postexposure viral shedding. (b) Timing of pre-exposure NCPT sessions.
Figure 4.3: Total post-exposure viral shedding and pre-exposure NCPT session timing. (a) Timing
of the pre-exposure NCPT testing sessions for each of the 18 challenge study participants during the
baseline part of the challenge study (0 to 80 hrs), which precedes exposure to the HRV pathogen.
Appearing on the far left of the figure are the subjects’ initial screening sessions which, for all
but two participants, occurred several days before the start of the study. At far right of the figure
is shown the total number of sessions, varying between 8 and 10, for each participant. (b) Total
amount of viral shedding accumulated from the time of exposure to the end of the study, indexed
over subjects ID’s. The subject ID encodes the subject index (numeric first two characters from 1 to
20) the subject gender (M or F second character) and whether the participants’s shedding is below
or above (0 or 1) the population median of total viral shedding (5.7 titers).
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4.6 Supplementary Materials















































Figure 4.4: Timing of sessions over the entire study (pre- and post-exposure) for the 18 participants.
The time axis is indexed over hours where 0h corresponds to 12AM of the first day of the challenge
study and 80h corresponds approximately to the time of viral inoculation on the morning of the 4th
day (8am). Figure 4.3b only shows the pre-exposure sessions.





















Histogram of inocculation times
=8am
Figure 4.5: Histogram of the inoculation times for the 18 participants. Eighty hours corresponds
to 8am on the morning of the 4th day of the challenge study. All but 2 participants are inoculated
between of 7 and 9am.
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Low shedder High shedder Total
Median Age (range) 21 (20-24) 20 (19-33) 20(19-33)
Gender
Male 8 4 12
Female 1 5 6
Ethnicity
White 7 7 14
Black 2 0 2
Asian 0 2 2
Dominant hand
Right 9 9 18
Left 0 0 0
Median Systolic BP (range) 120 (100-130) 110(100-120) 112(100-130)
Median Diastolic BP (range) 70 (60-80) 70 (58-79) 70 (58-80)
Median Pulse (range) 64 (60-72) 72 (60-80) 67 (60-80)
Median Respiratory Rate (range) 20 (16-20) 18 (16-20) 19 (16-20)
Median Weight (range) 71 (61-89) 65 (55-73) 67 (55-89)
Getup time
before 6:30 0 1 1
6:30-7:45 1 0 1
7:45-9:45 5 6 11
9:45-11 3 1 4
11-12 0 1 1
Bed time
10:15-12:30 5 5 10
12:30-1:45 4 2 6
1:45-3 0 2 2
Productive time
Morning 4 3 7
Afternoon 3 1 4
Evening 2 3 5
Night 0 2 2
Figure 4.6: Study demographics (upper 3 rows), physiological statistics, and self-reported
biochronicity (morningness) statistics (lower 3 rows) collected during screening for the 18 subjects
included in our analysis.
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Figure 4.7: Scatter plots showing association between cognitive data collected at screening, the
perceived stress scale (PSS) with the amount of viral shedding (left) and with the pre-exposure
















































































































































































































































































































































































































Figure 4.9: Scatter plots of proposed CPV score constructed over the pre-exposure time interval and





















































































































































































Figure 4.10: Heatmap of correlations between univariate CPV’s of each NCPT variable, CPV (the
maximum of the CPV’s) and viral titer. Six NCPT variables do not have significant correlations with
any other NCPT variable, titers, or CPV and are omitted. These are digSym-error, reaction-error,
trail-tutorialTime, trail-error, posner-tutorialError, posner-timeCongruent. Statistically significant
correlations (Fisher test at 0.05 level) are indicated. Besides CPV, 6 other univariate CPVs are also
significantly correlated with titer, including the CPV of digSym-correct and digSym-time, which
form a highly correlated block with CPV and titer. The significant pairs along with their confidence
interval and p-values are included in the Table 4.1.
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Variable 1 Variable 2 correlation p_value CI
CPV titer 0.88 1.90E-06 [0.69,0.95]
CPV digSym-time 0.81 5.18E-05 [0.55,0.93]
CPV digSym-correct 0.68 1.75E-03 [0.32,0.87]
titer posner-tutorialTime 0.61 7.78E-03 [0.19,0.84]
titer digSym-time 0.6 8.09E-03 [0.19,0.83]
titer trail-time 0.52 2.70E-02 [0.07,0.79]
titer digSym-correct 0.51 3.22E-02 [0.05,0.79]
titer posner-totalTime -0.5 3.27E-02 [-0.79,-0.05]
posner-Ncongruent posner-correctCongruent 0.95 9.55E-10 [0.88,0.98]
digSym-correct digSym-time 0.83 1.85E-05 [0.6,0.94]
posner-responseTime posner-timeIncongruent 0.69 1.51E-03 [0.33,0.88]
posner-responseTime posner-totalTime 0.61 6.77E-03 [0.21,0.84]
posner-tutorialTime posner-Ncongruent 0.52 2.84E-02 [0.06,0.79]
reaction-time posner-correct 0.68 1.93E-03 [0.31,0.87]
trail-layoutNum trail-time 0.62 5.72E-03 [0.22,0.84]
trail-layoutNum posner-timeIncongruent 0.48 4.29E-02 [0.02,0.77]

















































































































Figure 4.11: Heatmap of correlations between CPV and some of the other variables continuously
collected during the challenge study. 5 variables are omitted in this figure as they are not signifi-
cantly corrected with any other variable (digSym-error, reaction-error, trail-tutorialTime, trail-error,
posner-tutorialError, posner-timeCongruent)(vafs_p, offset_mean, temp_mean_sleep, temp_sd_day,
cortisol_JTK). Significant correlations are annotated with numbers. Observe that the CPV is
not significantly correlated (Pearson p-value < 0.05) with the self-reported fatigue scores VAFS
(VAFS_mean) or cortisol levels/periodicity. CPV is significantly correlated with the variation in
sleep duration (duration_sd), which was collected from the Empatica E4 wearable device using
sleep/wake segmentation algorithm [SZH+20]. Information on the statistically significant pairs or
correlations are included in Table 4.2.
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Variable 1 Variable 2 ρ p_value CI
CPV titer 0.88 1.90E-06 [0.69,0.95]
CPV PSS 0.62 5.73E-03 [0.22,0.82]
CPV duration_sd -0.5 3.91E-02 [-0.79,-0.03]
CPV vafs_sd 0.48 4.27E-02 [0.02,0.77]
CPV vafs_mean -0.46 5.3E-02 [-?,-?]
titer vafs_mean -0.51 2.98E-02 [-0.79,-0.06]
cortisol_mean cortisol_sd 0.93 3.52E-08 [0.81,0.97]
duration_sd offset_sd 0.77 3.06E-04 [0.46,0.91]
vafs_mean vafs_sd -0.7 1.36E-03 [-0.88,-0.34]
vafs_sd duration_sd -0.65 5.00E-03 [-0.86,-0.24]
duration_sd temp_mean_day -0.59 1.23E-02 [-0.84,-0.16]
duration_mean duration_sd 0.57 1.67E-02 [0.12,0.83]
duration_mean cortisol_sd 0.51 3.84E-02 [0.03,0.79]
vafs_mean temp_sd_sleep -0.49 4.42E-02 [-0.79,-0.02]
Table 4.2: Table of significantly correlated biomarkers (Fisher test at level 0.05) including CPV,
titers, and NCPT variables.
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Figure 4.12: Stepwise linear regression of viral titers on the NCPT covariates listed in Table 4.1a.
The goodness of fit R2 to titers is no better than obtainable using CPV as the sole predictor variable,
which only involves fitting a single parameter.
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Figure 4.13: Correlation dendogram for viral titers, symptom and the NCPT covariates listed in
Table 4.1a. The three NCPT variables included in the regression model are all on the right branch
of depth two.
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Figure 4.14: Panels indicate the distribution over subjects in the study of the univariate CPV of each
of the NCPT variables in Table 4.1a ordered in decreasing correlation to CPV (maximum of the
univariate CPVs).
Figure 4.15: Panels indicate the distribution over NCPT variables in Table 4.1a in the study of the
univariate CPV of each of the subjects, ordered from highest to lowest shedders.
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Figure 4.16: Boxplots of the univariate Cognitive Performance Variability scores over the 18 NCPT
variables in Table 4.1a for all participants. Plots are arranged from lowest shedding (top left) to
highest shedding (bottom right). challenge study participants. The Solid bluecurve denotes the CPV
scores computed for each NCPT variable using the full session sequence, but omitting the initial
screening session. Red boxplots show the distribution of the leave-one-out (loo) scores computed
by successively dropping a single session from the sequence of post-screening sessions.
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= 968 cross-validated CPV Pearson correlation coefficients
ρ, along with corresponding R squared and AUC for linear prediction of the amount of shedding and
classification using logistic regression onto Low vs High shedding (0,1) labels, respectively, using
the proposed maximum CPV score. The heatmap at bottom indicates the corresponding testing
time patterns, out of the 968 possible patterns of all combinations of T=3,4,. . . ,10 NCPT sessions
administered during the baseline period. For each T=3,4,...,9, the top 10 patterns are rank ordered in
decreasing order of the lowest cross-validated (leave-one-out) estimated value of ρ, excepting T=10
for which there is only one possible session pattern. The correlation coefficients, R2 and AUC all
degrade considerably when the reference session (1) is included in the calculation of the CPV.
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Figure 4.18: Zoomed version of previous figure showing the top 10 cross-validated CPV Pearson
correlation coefficients ρ for each category of number of sessions T = {3, . . . , 9} and the single
cross-validated CPV for T = 10 sessions.
NCPT variable No. of correlated gene Gene name ρ P value FDR
digSym_correct 33 LTF 0.515 5.93E-12 1.08E-07
digSym_error 3726 NRG1 0.621 5.12E-18 9.34E-14
digSym_time 23 ADGRG7 0.527 1.57E-12 2.86E-08
reaction_error 0 CHAC1 0.333 2.16E-05 3.94E-01
reaction_time 155 ADGRG7 0.527 1.58E-12 2.88E-08
trail_layoutNum 0 CKAP2L -0.333 2.20E-05 4.02E-01
trail_tutorialTime 1 KLRF2 0.409 1.19E-07 2.16E-03
trail_error 1 LHB 0.379 1.05E-06 1.91E-02
trail_time 0 MSRA -0.331 2.48E-05 2.53E-01
posner_tutorialError 0 DEPDC4 0.316 5.92E-05 6.70E-01
posner_tutorialTime 9 MIR4760 0.654 2.14E-20 1.95E-16
posner_correct 14 MIR550A2 -0.369 2.13E-06 3.61E-02
posner_responseTime 83 ADGRG7 0.541 2.98E-13 5.43E-09
posner_timeCongruent 87 ADGRG7 0.494 5.37E-11 9.80E-07
posner_timeIncongruent 5 ADGRG7 0.465 9.23E-10 1.68E-05
posner_totalTime 19 ADGRG7 0.504 1.91E-11 3.48E-07
posner_Ncongruent 0 GNAL 0.270 6.51E-04 1.00
posner_correctCongruent 0 GNAL 0.270 6.50E-04 1.00
Figure 4.19: Pearson correlation between NCPT variables and genes.
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Pathway Type Name FDR Odds Ration Pathway size Shared size
Transport and catabolism Phagosome 3.99E-03 2.269 132 48
Digestive system Protein digestion and absorption 4.90E-03 2.671 77 31
Digestive system Cholesterol metabolism 4.90E-03 3.770 41 20
Transport and catabolism Lysosome 6.46E-03 2.159 122 43
Infectious diseases: Viral Influenza A 7.59E-03 1.965 154 51
Infectious diseases: Parasitic Leishmaniasis 1.69E-02 2.605 63 25
Cancers: Overview Proteoglycans in cancer 2.18E-02 1.810 166 52
Immune system Chemokine signaling pathway 2.23E-02 1.794 167 52
Infectious diseases: Bacterial Salmonella infection 4.78E-02 2.189 73 26
Infectious diseases: Viral Kaposi sarcoma-associated herpesvirus infection 4.78E-02 1.695 177 53
Cancers: Overview Pathways in cancer 4.78E-02 1.387 464 120
Development Osteoclast differentiation 4.78E-02 1.839 123 39
Figure 4.20: Enriched pathways of genes significantly correlated with NCPT variables.
118
Figure 4.21: Top: Scatter of viral titers vs post-exposure CPV score. There is no no significant
correlation. Bottom: Scatter of post-exposure CPV vs pre-exposure CPV.
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CHAPTER 5
Conclusion and Future Directions
The significance of the contributions of this thesis might best be appreciated in the context of
the widely acknowledged fact that some of the highest ARVI risk factors are poor sleep, stress,
and fatigue. These risks reside both in the infected individual, i.e., personal morbidity associated
with severe infection, and in the infectious individual, i.e., super-spreaders infecting the rest of
the population, who may not be the same individuals. This thesis has exhibited new markers for
susceptibility to ARVI infection and infectiousness, measured according to viral shedding and
self-reported symptom levels, are related to stability of the cognitive, physiological and molecular
states of the individual. For the physiological and cognitive states we have shown that these markers
are associated with the temporal variations of the associated biomarkers over baseline, (sleep heart
rate, sleep duration) for the physiological state and cognitive performance on games for the cognitive
state. For the molecular states we have shown that it is the weakness and instability of the circadian
cycle over baseline that differentiates the severely infected from the others. Markers and risk factors
are not identical, however, so more work needs to be done to establish if these associations reflect
causal relationships or not.
The contributions of this thesis thus fit into the landscape inhabited by future technologies for
health maintenance, disease prevention, clinical medicine, and epidemiology. This would require
much larger scale controlled studies that go beyond the small observational studies producing the
data for this thesis. Such studies are strongly motivated by our results. This would permit validation
of our results on larger cohorts, possible teasing out causal associations, and expanding the domain
of applicability to demographics not well represented in the limited populations of the two available
challenge studies, which were primarily college age healthy individuals.
A potential future vision might be constructed from the results of Chapters 3 and 4, which show
that even a small duration segment of healthy baseline data suffices to learn digital biomarkers
that index susceptibility markers and risk factors. This raises the intriguing question of whether
variables can be found that, complementary to heart rate variation during sleep and cognitive
performance variability, index a wide array of markers or behavioral risk factors for other diseases,
e.g., Alzheimers, ALS, Parkinsons, addiction, etc. Could conveniently collectible, continuously
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collected digital biomarkers derived from wearables and smart phones/tablet platforms play a
significant role? With a much longer baseline it is conceivable that similar platforms might be used
to infer more specific information on the healthy baseline, permitting better discrimination of risky
deviations from baseline. With a sufficiently large corpus of labeled training data, perhaps collected
continuously during a lifetime, algorithms similar to ours’ could learn deviations from the baseline
that are benign vs those that are potential risk factors. This algorithm could raise an alarm or silently
cue complementary algorithms or measurements that might raise confidence on the benign nature of
the deviation. With sufficient experimental resources and time, such an algorithm could in principle
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